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Abstract 
 
 Spx is a global regulator discovered in Bacillus subtilis to suppress basal growth and 
development processes and activate transcription of genes involved in thiol homeostasis when a 
cell encounters oxidative stress.  Its activity relies on reversible thiol-disulfide bond formation 
and binding RNA polymerase rather than DNA.  The discovery that Staphylococcus aureus 
global virulence regulator, SarA, is more active upon cysteine reduction suggests that redox 
response could mediate virulence in this important human pathogen.  We describe the cloning of 
spx from S. aureus strain RN6390, overexpression in Escherichia coli, and purification of native 
protein.  Antibodies against Spx were raised for western analysis.  Spx from S. aureus was 
highly active in a B. subtilis in vitro transcription system, stimulating expression of trxB, the 
gene encoding thioredoxin reductase, without reducing agents.  RNA polymerase was partially 
purified from S. aureus, and the enzyme was active, catalyzing transcription of rpsD, but not 
trxB.   
 
 
 
 iv
Introduction 
 
 The Gram-positive coccus, Staphylococcus aureus, is an important human pathogen, 
causing a wide variety of diseases ranging in severity from superficial boils and abscesses to life-
threatening septicemia.  Depending on the tissue colonized, an S. aureus infection can result in 
bacterial meningitis, endocarditis, osteomyelitis, endophthalmitis, pneumonia, septic arthritis, 
toxic shock syndrome, and food poisoning.  However, the organism is also part of the normal 
human flora, existing innocuously on the skin or in the nasal passages of approximately one-third 
of the population.  Infection can result when a break in the skin or mucous membranes grants the 
commensal microbe access to the bloodstream or other tissues, defining S. aureus as an 
opportunistic pathogen, the potency of which can be attributed to its broad range of virulence 
factors, ability to withstand many environmental stresses and persist outside the host, and rapid 
evolution into multiple-drug resistant strains.   
 S. aureus is a prominent source of nosocomial infections.  This is due in large part to its 
ability to colonize medical apparatuses such as catheters, prosthetic implants and valves, and 
orthopedic devices.  Growth within prostheses allows the bacteria to enter musculoskeletal tissue, 
rendering it the leading cause of osteomyelitis (Frederiksen et al., 1993).  More important is the 
prevalence of multiple-drug resistant isolates within the hospital setting.  Treatment options for S. 
aureus infections are rapidly becoming obsolete as the number of antibiotic-resistant strains 
skyrockets.  Methicillin-resistant S. aureus (MRSA) currently constitutes over half of clinical 
isolates (Oliveira et al., 2002).  The evolution of MRSA strains resistant to vancomycin (Boyle-
Vavra et al., 2001; Weigel et al., 2003), a drug of “last resort,” constitutes an immediate threat to 
human health worldwide.  The ease with which the organism gains genetic elements to nullify 
traditional antimicrobials suggests that researchers must employ innovative strategies in 
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approaching the design of therapeutic agents.  To this end, the regulatory pathways by which S. 
aureus controls virulence factor production must be fully understood. 
 S. aureus produces two major classes of temporally-regulated virulence factors:  cell 
wall-associated proteins and secreted exoproteins.  The former class includes adhesins such as 
the collagen-, elastin-, and fibronectin-binding proteins (cna, ebpS, fnbA and fnbB), intracellular 
adhesin (ica), and clumping factor (clfA and clfB) (reviewed in Bronner et al., 2004).  
Staphylocoagulase (coa), although it is actually an extracellular protein, is also preferentially 
expressed with the surface-associated factors (Lebeau et al., 1994).  Expressed in the early stage 
of infection or at the onset of exponential growth phase in culture, these proteins allow the 
bacteria to colonize host tissue and navigate the bloodstream.  Protein A (spa) binds the Fc 
portion of circulating antibodies, thus rendering the burgeoning colonies invisible to the host’s 
immune system (King and Wilkinson, 1981).  A global phenotypic switch occurs later in 
infection or during the late exponential phase in culture, whereby the expression of surface 
proteins is suppressed in favor of the latter class of virulence factors.  The secreted proteins 
include exoenzymes, such as proteases (eta, etb, sspA, sspB, and spl), lipase (geh), and nuclease 
(nuc), and toxins, including classes of hemolysins (hla, hlb, hld), leukotoxins (luk), enterotoxins, 
exotoxins (set), and toxic-shock syndrome toxin (tst) (reviewed in Bronner et al., 2004).  In vitro, 
this is likened to cells scavenging for nutrients as the requirements of the colony exceed the 
resources of the media;  in vivo, this may represent a mechanism by which cells release 
themselves from attachment sites and disseminate from the primary infection site once it has 
been established (Wesson et al., 1998).   
 The temporal regulation of the above factors is coordinated by a number of 
pleiotropically-acting regulators, most notably of the unlinked sar and agr loci, but also 
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including sae (Giraudo et al., 1997), ssrAB (Yarwood, et al., 2001),  mgr,  and several Sar 
homologs (sarT, sarU, sarV and rot) (reviewed in Novick, 2003).  The agr locus (accessory gene 
regulator) consists of two adjacent, divergent transcripts, RNAII and RNAIII, expression of 
which are driven by the P2 and P3 promoters, respectively (Peng et al., 1988).  RNAII encodes 
four genes (agrABCD), which comprise an autoregulatory quorum-sensing circuit with a 
classical two-component sensory transduction system having genomic sequence and organization 
similar to the comAP operon of Bacillus subtilis (Dubnau et al., 1994).  AgrD, the signaling 
peptide, is post-translationally processed into an octapeptide pheromone, cyclized, and exported 
from the cell by AgrB (Ji et al., 1995).  AgrC, a membrane-bound histidine kinase, senses the 
extracellular concentration of the signaling peptide, and, once it has reached the minimum 
threshold of concentration due to a cell density corresponding to late exponential phase in culture, 
phosphorylates the response regulator, AgrA.  AgrA, thus activated, binds the P2 and P3 
promoters within the agr intergenic region, and upregulates expression of both transcripts 
(Koenig et al., 2004).  RNAIII, the effector molecule of the system, is an untranslated regulatory 
RNA molecule that incidentally includes the open reading frame (ORF) for δ-hemolysin (hld).  
RNAIII, by a largely unknown mechanism, operates at the level of transcription and translation 
to decrease the production of cell-surface proteins and initiate the secretion of exoproteins 
(Novick et al., 1993; Morfeldt et al., 1995; Korem et al., 2005).  Mutants lacking any gene of the 
agr locus exhibit highly reduced virulence in animal models of disease (Abdelnour et al., 1993; 
Cheung et al., 1994; Gillaspy et al., 1995). 
 The sar (staphylococcal accessory gene regulator) locus was first described as a locus 
distinct from agr, which changed the overall pattern of virulence gene expression when 
inactivated (Cheung et al., 1992), and then as a gene required for optimal expression of agr 
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(Cheung and Projan, 1994).  It contains three overlapping transcripts (sarA, sarB, and sarC) with 
a common termination signal (Bayer et al., 1996), and all encode the 14.5 kDa DNA-binding 
protein, SarA (Cheung and Projan, 1994).  SarA forms a dimer in solution (Rechtin et al., 1999) 
and is shown to upregulate expression of both RNAII and RNAIII by binding cis to the P2 and 
P3 promoters (Morfeldt et al., 1996; Chien and Cheung, 1998; Chien et al., 1999).  Yet sar also 
affects expression of virulence determinants independently of agr (Cheung et al., 1994; Blevins 
et al., 1999; Chien et al., 1999; Wolz et al., 2000), and mutant strains of S. aureus with sar or 
agr  mutated can have quite different phenotypes (Cheung et al., 1992; Blevins et al., 1999; 
Blevins et al., 2002).  Although the literature is inconsistent with regards to whether SarA 
represses or induces certain genes, particularly those encoding exoproteins, it does appear to 
repress cna and spa transcription (Cheung et al., 1997; Chan and Foster, 1998; Chien et al., 
1999) and enhance fibronectin-binding capacity (FBC) (Cheung et al., 1994; Wolz et al., 2000).  
sar mutants show attenuated virulence compared to the wild-type, and sar agr double mutants 
have diminished virulence in comparison to agr mutants (Cheung et al., 1994). 
For many years, SarA was believed to be a classical transcription factor; however, 
mounting evidence to the contrary indicates that it is not.  SarA is thought to affect over 100 
genes as either an activator or a repressor, and though much of its influence may be through 
other regulators, it has been shown to bind directly to promoter regions of a number of target 
genes. A number of laboratories have identified different binding sites for SarA within the agr 
intergenic region (Morfeldt et al., 1996; Chien and Cheung, 1998; Chien et al., 1999; Rechtin et 
al., 1999; Sterba et al., 2003).  An AT heptad repeat identified by SELEX (selective evolution of 
ligands by exponential enrichment) as a consensus SarA binding site (Sterba et al., 2003) is 
present in over 2500 copies within the S. aureus genome (Roberts et al., 2006).  SarA is present 
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in the cytoplasm in copy numbers far exceeding any known transcription factor (Fujimoto et al., 
unpublished data).  SarA has also been shown to influence mRNA turnover, stabilizing cna and 
spa transcripts, evidence which suggests that genetic regulation by SarA may not be entirely at 
the level of transcription (Roberts et al., 2006).        
 Confounding an understanding of virulence gene regulation in S. aureus is the discovery 
by several laboratories of strain-dependent differences in sar- and agr-mediated gene expression 
(Li et al., 1997; Papakyriacou et al., 2000; Blevins et al., 2002; Peacock et al., 2002; Cassat et 
al., 2005).  The bulk of genetic data on S. aureus has focused on the common laboratory strain 
RN6390, or its parent, NCTC8325-4 (Novick, 1967).  However, this strain has long been known 
to carry an 11-bp deletion in rsbU, which encodes a positive regulator necessary for activation of 
the stress response sigma factor, σB, rendering it essentially a sigB mutant (Kullick et al., 1998).  
It would therefore be expected that RN6390 would be deficient in its defenses against 
environmental stresses, which may, in turn, attenuate virulence; indeed, this appears to be the 
case.  It is also lacking in cna, which promotes collagen binding.  Although wild-type RN6390 is 
virulent in animal models of disease, its pathogenicity is greatly attenuated, even when a 
chromosomal copy of cna is introduced, in comparison to clinical isolates of S. aureus (Blevins 
et al., 2002; Cassat et al., 2005).   
 Blevins et al. (2002) compared the effects of mutations of agr and/or sar within three 
laboratory strains, including RN6390, to those within four clinical isolates, and found a 
surprisingly different pattern of virulence gene regulation among the different strains.  Although 
sar mutants all exhibited increased protease expression and decreased FBC and mutations of agr 
brought forth the opposite effect, the impact of these mutations was hardly uniform among the 
different strains.  For instance, the decrease in protease expression was barely significant in 
 5
clinical isolates but quite obvious in RN6390; however, wild-type RN6390 was shown to be 
proteolytically hyperactive compared to wild-type clinical isolates (Blevins et al., 2002).  The 
significance of this finding is highlighted by the observation that epidemic strains of S. aureus 
generally limit exotoxin release to booster host protein-binding capacity, which may favor the 
colonization phase of infection (Papakyriacou et al., 2000).  Moreover, it was found that the sar 
mutant’s diminished FBC was not due to decreased fnb transcription, but the rise in proteolysis, 
particularly by sspA.  Mutations of sar also produced disparate phenotypes in regard to 
hemolysis:  in RN6390, hemolysis was negatively impacted by both sar and agr mutations in 
accord with the findings of Cheung and Ying (1994); in all other strains tested, the sar mutants 
gained hemolysin activity.  Again, the hemolysin production of wild-type clinical isolates was 
greatly reduced compared to that observed in wild-type RN6390 (Blevins et al., 2002).  Finally, 
in stark contrast to the findings of Cheung and Projan (1994), mutating sar seemed to have little 
effect on RNAIII expression in all strains except RN6390 (Blevins et al., 2002). 
 Cassat et al. (2005) performed a genome-wide comparison of RN6390, seven sequenced 
strains, and two clinical isolates, and used hierarchical clustering to establish that RN6390 is 
actually an outlier strain in regards to genetic relatedness.  All of the clinical isolates tested were 
closely linked, including EMRSA-16, the MRSA dominant in the United Kingdom (Moore and 
Lindsay, 2002).  These strains were found to be more infective at lower doses than RN6390 and 
its close relatives.  The researchers also determined that cna, which RN6390 lacks, is not only a 
marker for overall virulence, but for genetic relatedness as well (Cassat et al., 2005).  This agrees 
with an earlier report stating that S. aureus strains which encode cna account for the majority of 
human infections (Booth et al., 2001). 
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 It is apparent from these studies that the regulatory circuits controlled by agr and sar in 
RN6390 are not representative of those in clinical isolates, and further characterization of these 
global regulators within the background of the laboratory strain may be pointless.  What is not 
readily apparent is the source or sources of this discrepancy.  One possible explanation is that 
SarA is not maximally expressed in RN6390 due to the lack of sigB activity.  Deora et al. (1997) 
purified σB from S. aureus and used it in in vitro transcription of SarA from all three promoters.  
They discovered that transcriptional activation from the P3 promoter of sarC, which is 
intermediate in size to the other two transcripts, is σB-dependent (Deora et al., 1997).  Another 
laboratory verified this result in vivo using transcriptional fusion experiments (Manna et al., 
1998).  Blevins et al. (2002) also found reduced levels of sarC transcript in RN6390, but it did 
not result in decreased SarA production.  Another laboratory determined that SarA activity was 
dependent not only on functional σB, but growth phase, as well, with maximal SarA expression 
occurring during late exponential growth in a sigB-positive strain.  They also found agr 
expression was increased in sigB mutant strains.  σB appeared to have an inhibitory effect on 
FBC in this study (Bischoff et al., 2001).  It should also be mentioned that at least one laboratory 
concluded that σB plays no role in pathogenesis by S. aureus (Chan et al., 1998). So while it is 
tempting to suggest that RN6390 has a phenotype similar to a sar mutant because of the rsbU 
deletion, definitive evidence remains elusive.  An otherwise isogenic strain of RN6390 encoding 
functional sigB does exist (Horsburgh et al., 2002).  If experiments performed in RN6390 were 
replicated in this strain (SH1000), the role of σB in global gene expression could be better 
characterized. 
 The discovery by Bischoff et al. (2001) that optimal SarA expression was dependent not 
only on σB, but on growth stage also, suggests that environmental stimuli and stress response 
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may be involved in SarA expression and SarA-mediated expression.  Chan and Foster (1998b) 
examined expression of hla, tst, and several putative extracellular proteases under aerobic and 
microaerobic conditions.  Their results were rather inconsistent:  a sar mutant had ten-fold 
accumulation of Hla compared to the wild-type as measured by NH2-terminal sequencing of the 
exoprotein profile;  the same mutant had 40 % activity relative to wild-type in a hla:lacZ 
transcriptional fusion experiment.  They did find that SarA seems to be a general repressor of 
proteases, in accordance with the bulk of literature on S. aureus, and hypothesized that the 
discrepancy concerning Hla accumulation and activation could be a result of proteolysis of Hla 
by various secreted proteases, notably a prominent V8 serine protease.  They also argued that 
differential protease expression could be a mechanism to control a wide range of responses, 
including to stresses and environmental stimuli.  One rather intriguing piece of evidence pointing 
to a potential role for SarA in stress response was that hla activation, as measured by the lacZ 
fusion, was dampened in the sar mutant under microaerobic conditions even compared to normal 
growth conditions.  They also noted that hla expression was induced earlier under microaerobic 
conditions (Chan and Foster, 1998b).  It seems possible that exponential-phase cells could 
behave like post-exponential phase cells when undergoing environmental stress or as the media 
becomes depleted of nutrients and saturated with waste products, and this reaction could involve 
alternate sigma factors, SarA, and other regulatory networks.  
 Morfeldt et al. (1996) noted that the spacing between the -35 and -10 elements of P3 
promoting RNAIII transcription was three base pairs too long for optimal recognition by RNAP, 
and hypothesized that SarA may function to change DNA topology so RNAP and possibly other 
regulators could interact with S. aureus promoters (Morfeldt et al., 1996).  Supporting this 
hypothesis is the intrinsic curvature of DNA within AT-rich tracts that SarA is known to bind to 
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(Sterba et al., 2003).  SarA activates expression of a murein hydrolase encoded by lrg, and this 
activity was shown to be dependent on a region of intrinsic DNA curvature (Fujimoto et al., 
2000).  It must be stated, however, that while an early published report of the crystal structure of 
SarA binding DNA supported this theory showing SarA overwinding B-DNA into D-DNA upon 
contact (Schumacher et al., 2001), a later report found SarA and DNA made more traditional 
activator-promoter interactions (Liu et al., 2006).  Yet evidence still accumulates that SarA may 
more resemble an accessory protein analogous to Xis from Escherichia coli or Integration host 
factor (IHF) from bacteriophage λ, which promote intramolecular excision recombination and 
Integrase-mediated recombination, respectively (Mumm et al., 2006), than a transcription factor 
in the usual sense.  SarA could replace Xis in in vitro intramolecular recombination reactions, 
although with only modest stimulation of excisional activity, and could bind the bacteriophage λ 
attachment site, attL, forming complexes resembling intasomes (Fujimoto et al., unpublished 
data).  The DNA substrates employed in these assays, attL and attR, contain a site, X, which is 
AT-rich (75%), mirroring the AT-richness of the S. aureus genome, and containing a SarA 
binding site previously identified by SELEX (Fujimoto et al., unpublished data; Sterba et al., 
2003).  This evidence suggests that SarA has a high affinity for AT-rich DNA, such as is found 
in UP elements (Ross et al., 1993), and that activation and repression of target genes by SarA 
may be an indirect consequence of its chromosomal accessory protein activity. 
 In the above study, Fujimoto et al. performed competitive enzyme-linked immunosorbent 
assays (ELISAs) with cell-free extracts of S. aureus competing against purified SarA for 
antibody, and discovered that there are approximately 50,000 SarA dimers per cell at all stages 
of growth (Fujimoto et al., unpublished data).  This number far exceeds cellular quantities of 
known transcription factors, and is similar to amounts of nucleoid accessory proteins found in E. 
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coli (Johnson et al., 2005).  Fujimoto et al. also determined that, contrary to previous reports 
(Bischoff et al., 2001; Manna and Cheung, 2001),  SarA is equally active at all stages of growth 
in vitro, which caused the researchers to question why the literature continually shows SarA 
exerting its regulatory effects in late- and post-exponential stages of growth in vivo.  Recalling 
the discovery by Chan and Foster (1998b) that SarA activity changed under microaerobic 
conditions, Fujimoto et al. performed electromobility shift assays (EMSAs) of SarA binding to 
three promoter regions (for agr, cna, and sspA) under oxidizing and reducing conditions.  They 
observed a dramatic increase of SarA activity when thiol-specific reductants, dithiothreitol 
(DTT) and β-mercaptoethanol, were added to the reactions and a decline in activity when 
hydrogen peroxide was used.  The redox response of SarA was shown to be mediated by its lone 
cysteine residue at position nine:  the C9A mutant had maximal activity under all conditions 
tested.  Similarly, SarA’s DNA-binding affinity was also responsive to changes in pH, with 
affinity increasing as the pH decreased and optimal binding measured at a pH of 5.5.  Again, this 
response appears to be dependent on C9, as the C9A mutant’s activity was maximal at a pH of 
7.5 (Fujimoto et al., unpublished data).  agr expression was earlier found to be favored by low 
pH, which may be a consequence of SarA’s binding cis to the agr promoter regions (Regassa and 
Betley, 1992; Regassa et al., 1992).   
The enhancement of SarA activity caused by low pH and lack of oxygen may explain 
why researchers have generally concluded that SarA exerts its regulatory effects during post-
exponential growth, as culture media tends to accumulate acidic waste products, and denser 
colonies may be less efficiently aerated.  More importantly, however, is the logical inference that 
this may better represent the environment S. aureus encounters during an actual infection, where 
conditions will be far from the monospecific, highly aerated, nutrient-rich cultures typically used 
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in a laboratory.  Within the host, an invading pathogen will encounter environmental stresses 
such as release of reactive oxidative species from macrophages, high temperatures induced by 
fever, acidic pH of phagolysosomes, and anaerobic conditions found within an abscess.  S. 
aureus, being a facultative anaerobe, can grow without oxygen, and anecdotal evidence has 
pointed to a heightening of virulence when it does, as was seen with toxic shock syndrome.  
SarA may therefore be a chromosomal architecture protein which prepares the cell for 
environmental stress it will encounter during stationary phase growth while it coordinates 
virulence gene regulation with agr and other regulators.     
 Prokaryotes must contend with oxidative-reductive (redox) stress as a consequence of 
aerobic respiration, residence within a host, and competition from other microbes.  In general, 
redox stress is caused by exposure to reactive oxygen intermediates (ROIs), such as the 
superoxide anion (O2·-), hydrogen peroxide (H2O2), and hydroxyl radical (HO·) (reviewed in 
Bauer et al., 1999).  O2·- and H2O2 are normal byproducts of oxidative phosphorylation, formed 
when molecular oxygen oxidizes electron carriers along the respiratory chain.  They are also 
released from macrophages as part of the host defense to infection.  Bacteria secrete redox-
cycling antibiotics to inhibit growth of competitors.  O2·- destroys iron-sulfur clusters found in 
many enzymes.  Iron released can react with H2O2 to form HO·, which damages DNA and 
oxidizes free thiol residues within proteins into disulfide bonds (reviewed in Storz and Imlay, 
1999). Formation of nonnative disulfide bonds causes protein misfolding, and is a common 
mechanism for proteins to gain or lose activity (Åslund and Beckwith, 1999).  Cytoplasmic 
proteins generally do not contain structural disulfide bonds due to the reducing environment 
within the cell, but are found in the periplasm (Stewart et al., 1998).  O2·-, which cannot cross the 
plasma membrane at neutral pH, can combine with nitric oxide (NO·) to form HOONO.  
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HOONO can diffuse across the membrane into the cytoplasm, where it is free to attack iron-
sulfur clusters and free thiols, inactivating enzymes.  Alone, NO· blocks respiration by binding 
hemes and metal cofactors of enzymes (Storz and Imlay, 1999).   
 Prokaryotes have evolved a number of different mechanisms to sense and respond to 
environmental or cellular increases in oxygen and ROIs (reviewed in Bauer et al., 1999).  The 
purpose of redox regulation is to maintain a steady state concentration of ROIs that is within the 
limit of tolerance (reviewed in Zheng and Storz, 2000).   One method by which this aim is 
achieved is through induction of genes involved in transport, such as porins and pumps, which 
exclude redox-active enzymes to stabilize oxygen levels (Storz and Imlay, 1999).  Two of the 
best characterized prokaryotic redox regulators are OxyR and SoxR from E. coli.  OxyR 
functions as a tetramer, with each monomer possessing two cysteine residues.  In the normal 
reducing environment of the cell, the cysteines exist as free thiols, but an increase in H2O2  
concentration oxidizes them into disulfide bonds.  OxyR, thus activated, binds upstream 
promoter elements of its regulon to upregulate transcription of genes encoding catalase (katG), 
alkyl hydroperoxide reductase (ahpF), glutaredoxin (grx), and glutaredoxin reductase (gorA) 
(Storz et al., 1990; Zheng et al., 1998).  SoxR is a homodimer, which contains four iron-sulfur 
clusters.  In its reduced form, it is inactive, but is activated by oxidation of the clusters by O2·- or 
nitric oxide.  Activated SoxR then upregulates the transcription of soxS, which relays the redox 
response by initiating transcription of genes such as superoxide dismutase (sodA), aconitase 
(acnA), fumarase (fum), and DNA repair enzymes like recA (Ding and Demple, 1997).  The 
oxidation events that lead to activation of both of these regulators are reversible, so the cascade 
of events ceases upon return of the cell to a reduced state (Zheng and Storz, 2000).  Another 
redox sensor, ArcB, is an intramembrane histidine kinase, which phosphorylates its cognate 
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response regulator, ArcC, depending on the redox state of the plasma membrane (Bauer et al., 
1999). 
 S. aureus is a facultative anaerobe, meaning that it can grow aerobically or anaerobically, 
either by fermentation or by respiration, using an alternative terminal electron acceptor to oxygen, 
such as nitrate.  Therefore, it must have sensory transduction pathways to gauge the oxygen 
content of its environment in order to optimize gene expression.  One of these systems, 
characterized in B. subtilis, is ResDE (Nakano et al., 1996), which has S. aureus homologs, 
SrrAB.  In B. subtilis, ResDE is required for anaerobic respiration when nitrate is the terminal 
electron acceptor.  The response regulator, ResD, is constitutively autophosphorylated, but ResE 
has phosphatase activity when oxygen is present.  Upon oxygen limitation, ResE loses its activity, 
and ResD becomes active, inducing transcription of its regulon, which includes essential genes 
for anaerobiosis (Nakano et al., 2000b).  Another role of oxidoreductases in the cell is to provide 
reducing power for biosynthetic enzymes, such as the ribonucleotide reductases which are 
necessary for nucleic acid synthesis.  The source of reducing power is generally NADPH 
(Reichard, 1993).  In S. aureus, three classes of ribonucleotide reductases exist, and are 
differentially expressed depending on oxygen availability.  Class Ib is oxygen-dependent, Class 
II is oxygen-independent, and Class III is only expressed during anaerobic growth.  This ability 
of staphylococci to sense oxygen levels ensures that this essential activity will not be lost 
(Masalha et al., 2001). 
 The first attempt to characterize the transcriptome of S. aureus cells experiencing 
oxidative stress was made by Chang et al. (2006).  They subjected the cells to hydrogen peroxide 
for 10-20 minutes, and analyzed the pattern of gene expression during the onset of, and recovery 
from, stress, and noted an initial period of repression of iron storage and transport genes, during 
 13
which time genes involved in fermentation were being upregulated.  They concluded that S. 
aureus has the ability to induce an anoxic state, and can thus limit its exposure to oxygen and 
resultant cytotoxicity (Chang et al., 2006).  Another group also reported that suppression of the 
tricarboxylic acid cycle through aconitase inactivation actually enhances stationary phase 
survival of S. aureus.  Their hypothesis was that this is a naturally occurring event, where an 
irreversible loss of the iron-sulfur cluster in aconitase renders the pathogen less susceptible to 
ROIs produced by host macrophages (Somerville et al., 2002).  In light of this evidence, it seems 
highly likely that S. aureus can maximize its infectivity through modulation of redox-dependent 
gene expression, and that redox sensors and regulators might cooperate with virulence 
determinant factors, like SarA, to accomplish this aim. 
   The discovery that virulence gene regulation by SarA, and perhaps agr, is dependent on 
redox has led our laboratory to investigate a novel global redox regulator, spx.  This gene was 
well characterized in B. subtilis by the group led by Peter Zuber.  It has sequence and structural 
homology to the enzyme, arsenate reductase (arsC), first located on S. aureus plasmid pI258 
(Martin et al., 2001).  Arsenate reductase functions in anaerobic respiration, allowing arsenate to 
be used as the terminal electron acceptor, and in staphylococci, its activity is dependent on 
hydrogen donation by thioredoxin (trxA) and thioredoxin reductase (trxB) (reviewed in Silver 
and Phung, 2005).  However, Spx was found to be a transcriptional activator and repressor with a 
mode of activity unique among known prokaryotic transcription factors. 
spx (originally named yjbD) was discovered in B. subtilis as the site of suppressor 
mutations that overcame growth and development deficiencies in clpP and clpX strains (Nakano 
et al., 2001).  The Clp (casinolytic proteolytic) complex is composed of the ClpP proteolytic 
subunit and one of three substrate-binding components:  ClpX, ClpC, or ClpE.  ClpX is an 
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ATPase and unfoldase that denatures substrate proteins and translocates them into the proteolytic 
chamber of ClpP, imparting specificity in the energy-driven reactions (reviewed in Hecker et al., 
1996). Alone, ClpX acts as a molecular chaperone.   It also aids in the displacement of σA, the 
housekeeping σ, in favor of σH, the sporulation factor, and stimulates σH-dependent transcription 
of sporulation genes (Liu and Zuber, 2000).  ClpP functions as a heptamer, and without an 
ATPase unit, can only degrade small peptides (Krüger et al., 2000).  ClpXP is a crucial member 
of the cellular response team to heat and other stresses, and mutations of it are highly pleiotropic, 
restricting growth and preventing competence, sporulation, and biosynthesis.  Six clpXP 
suppressor mutations (denoted cxs) were isolated, and mapped to two unlinked loci: in rpoA, 
encoding the α subunit of RNA polymerase (RNAP), specifically helix 1 of the α-carboxy 
terminal domain (α-CTD) (Nakano et al., 2000a), and a novel gene, yjbD (Nakano et al., 2001).  
Helix 1 is important for interaction with activator domains of transcription factors (Russo and 
Silhavy, 1992), and making contacts with UP elements of promoter DNA (Ross et al., 1993; 
Gourse et al., 2000).  The mutations, Y263C (rpoA cxs-1) and V260A (rpoA cxs-2) changed two 
residues that are highly conserved in low GC-content Gram positive bacteria (Nakano et al., 
2000a).  Within yjbD, one nonsense (cxs-10) and three missense (cxs-5,-7,-12) mutations were 
isolated (Nakano et al., 2001), also in residues that are conserved in yjbD orthologs found in 
Gram positive bacteria (Zuber, 2004).  yjbD was renamed spx, suppressor of clpX and clpP 
(Nakano et al., 2002a).   
 In addition to regulating proteolysis, ClpXP plays an important role in initiating 
transcription of genes required for competence.  The development of competence in B. subtilis is 
regulated by the intricate com operon.  The concentration of ComX, a quorum-sensing 
pheromone, is sensed by ComP, a membrane-bound sensory kinase.  ComP phosphorylates its 
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cognate response regulator, ComA, which, in turn, activates transcription of srf.  srf encodes a 
peptide, ComS, which liberates ComK, a transcription factor for late competence genes, from an 
inhibitory complex.  ComK is sequestered by ClpCP and the adaptor protein, MecA, until ComS 
replaces it and presents itself as a target for proteolysis.  ComK then activates transcription of 
itself and genes involved in DNA uptake, repair, and recombination (reviewed in Dubnau et al., 
1994).   
 In clpP and clpX strains, which did not develop competence, but not in the wild type, Spx 
was discovered to bind to the proteolytic complex, and actually enhance the inhibition of ComK 
(Nakano et al., 2002a).  Western analysis of wild type and mutant strains revealed that Spx is 
barely detectable in wild type and clpC cells, but accumulates in clpX and clpP mutants (Nakano 
et al., 2002b).  Spx has a C-terminus resembling an SsrA peptide tag (Nakano et al., 2003a), 
which is co-translationally appended to a truncated peptide, targeting it for degradation by 
ClpXP or a similar protease (Weigert and Schumann, 2001).  Based on this evidence, and the 
phenotypes of clpX/P strains with concurrent restoration of competence in a clpX/P spx double 
mutant (Nakano et al., 2001), it seemed likely that ClpXP was necessary for degradation of Spx 
in order for cells to overcome Spx-dependent blocks to competence, and, presumably, 
sporulation and growth, as well (Nakano et al., 2002b).  However, Spx was not degraded by 
ClpXP in in vitro proteolytic reactions, but by ClpCP with an adaptor protein (Nakano et al., 
2002b).  This puzzling result turned out to be an artifact, caused by two amino acids appended to 
the C-terminus of the purified protein after the His-6-tag was cleaved.  This was remedied by 
cloning the tag onto the N-terminus, where the extension did not affect substrate recognition by 
ClpXP, which then successfully proteolyzed Spx in vitro (Nakano et al., 2003b).             
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 The activity of Spx was further characterized by examining its effect on expression on 
srf-lacZ and hmp-lacZ fusion proteins (Nakano et al., 2003b).  hmp encodes flavohemoglobin, 
and is induced under oxygen-limiting conditions by the two-component ResDE activator 
(Nakano et al., 2000b).  A clpX strain showed repression of both genes, but this defect was 
eliminated in clp cells bearing the rpoAcxs-1, rpoAcxs-2, spxcxs-16 (R52G) or spx null mutations, and 
also in the wild type, where Spx is presumably degraded.  These data suggested that Spx might 
inhibit gene expression by association with the α-CTD of RNAP, a hypothesis which was tested 
using a yeast two-hybrid experiment to search for proteins which interact with wild type, but not 
mutant alleles, of Spx.  Two positive clones both encoded rpoA, and the result was verified with 
a pull-down assay.  Spx activity was further elucidated by IVT of srf and hmp, transcription of 
which was repressed by the addition of Spx to reactions containing promoters with their cognate 
activators and wild-type RNAP, but not with cxs alleles.  The rpoA mutants, with or without Spx, 
transcribed a control gene, rpsD, indicating it encodes an otherwise functional enzyme.  The 
mechanism by which Spx could interrupt activator-dependent transcription was analyzed using 
EMSAs of srf and hmp, where Spx destabilized complexes formed by RNAP, promoters, and 
activator proteins (Nakano et al., 2003b).  Spx was also shown in vivo to repress genes involved 
in transport and utilization of alternative sulfur sources when cells were grown in the presence of 
the preferred source, sulfate (Erwin et al., 2005).  These experiments convincingly demonstrated 
that Spx affects gene expression by an apparently unique mechanism, blocking activator-
stimulated transcription by binding to the α-CTD of RNAP, rather than promoter DNA, 
prompting Spx to be dubbed an “anti-α” factor (Nakano et al., 2003b). 
 In order to examine the effects of Spx in vivo in a clpXP+ background, a mutant allele of 
Spx (spxDD) was constructed, which removed the SsrA peptide tag-like amino acids from the 
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carboxyl terminus (A130D, N131D), rendering it unrecognizable as a substrate for ClpXP.  
SpxDD accumulation in otherwise isogenic cells mirrored that of clp strains, and its repression of 
srf and nonproductive interaction with rpoAcxs was unchanged.  Total RNA was isolated from B. 
subtilis strains bearing SpxDD and either wild type RNAP or rpoAcxs-1, and used for microarray 
analysis of genome-wide expression.  176 genes were found to be repressed at least three-fold in 
cells carrying the wild type allele of rpoA:  as expected, these included the srf operon, and also 
many genes involved in growth and metabolic processes, such as purine, pyrimidine, and amino 
acid biosynthesis (Nakano et al., 2003a).  More surprising was the number of genes (106) 
induced at least three-fold by the Spx-RNAP interaction (Nakano et al., 2003a), several of whose 
products function to regulate thiol homeostasis in the cell, chief among them trxA (thioredoxin) 
and trxB (thioredoxin reductase).  Nearly half of the affected genes in the transcriptome of 
spxDD–expressing cells (Nakano et al., 2003a) followed a similar pattern of induction and 
repression to that of B. subtilis cells treated with a thiol-specific oxidant, diamide (Leichert et al., 
2003).  Diamide reacts with free thiols to form a disulfide bond with hydrazine as its end product 
(reviewed in Kosower and Kosower, 1995).  This strong correlation led the researchers to 
examine Spx-dependent regulation of trxA, trxB, and srf in cells undergoing diamide-induced 
stress using primer extension analysis.  As predicted, Spx inhibited transcription of srf, and 
activated trxAB when native RNAP was the catalyst.  Cells bearing cxs or spx null mutations 
were also hypersensitive to growth on 50 µM diamide, indicating Spx to be an important 
component of the cellular response to oxidative stress (Nakano et al., 2003a). 
 Thus, Spx was characterized as a unique global transcriptional regulator that functions to 
halt normal growth and metabolism in order to devote the cell’s transcriptional machinery to 
cope with thiol-specific oxidative stress, such as that incurred by treatment with diamide.  Under 
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normal conditions, Spx is proteolyzed by ClpXP, but accumulates under disulfide stress to block 
basal transcription, which explains the growth defects observed in clp mutants (Nakano et al., 
2003b).  These effects are transient:  at the onset of stress, cell growth is arrested, but resumes 
after diamide is consumed and detoxified (Leichert et al., 2003).  Although suppression of 
transcription by Spx is easily envisioned, the mechanism by which it activates genes involved in 
the stress response is more mysterious, as it has no DNA-binding domain (Zuber, 2004).  Besides 
trxAB, Spx induces tpx (thiol peroxidase), msrA (peptide methionine sulfoxide reductase), and 
various thioredoxin-like proteins (Nakano et al., 2003a).  It could inhibit expression of a 
repressor of a target gene, or recruit RNAP to an activator through protein-protein interactions 
(Zuber, 2004).  Also unclear is how Spx is stabilized under disulfide stress.  ClpXP could be 
diverted to focus on proteolysis of proteins damaged by oxidation or it could be inactivated itself.  
If so, it is likely the ClpX subunit that is affected, because ClpP and ClpC, but not ClpX, are 
induced over ten-fold upon diamide treatment (Leichert et al., 2003).  The N-terminal of ClpX 
has a zinc-finger domain, in which a zinc atom is chelated by five cysteine residues, the 
oxidation of which could result in irreversible loss of the bound zinc, and therefore, ClpX 
activity (Banecki et al., 2001).   
 Nakano et al. (2005) explored the mechanism by which Spx activates transcription of 
trxB by mutating the highly conserved cysteine residues at positions 10 and 13.  These form a 
CXXC motif, which is a common feature of redox sensors (OxyR), and a likely candidate for 
oxidative sensing and response (Åslund et al., 1999).  Cells bearing Spx with either C to A 
mutation were hypersensitive to diamide, and could not induce transcription of trxAB.  These 
residues were not involved in stability of Spx, as either mutant accumulated at the onset of 
diamide treatment, indicating that they are involved in transcriptional activation of and/or 
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binding to the α-CTD of RNAP.  IVT of trxB could only be accomplished when wild-type Spx 
was present in the reaction and was abolished with inclusion of the thiol-specific reductant, DTT, 
leading the researchers to conclude that formation of a disulfide bond activates Spx in regards to 
positive transcriptional regulation of trxB.  They convincingly established that the cysteine 
residues at positions 10 and 13 form an intramolecular disulfide bond by performing electro-
spray ionization mass spectrometry (ESI-MS) on Spx in the presence of an alkylating reagent, 
iodoacetamide.  Iodoacetamide alkylates free thiol residues.  No alkylation was detected unless 
DTT was present (Nakano et al., 2005), even when a strong denaturant was added to remove the 
possibility that free thiols could be inaccessibly buried within the protein’s hydrophobic core 
(Messens et al., 2004).  When DTT was added, acetylation occurred, and the resultant species 
had a mass similar to an Spx monomer, indicating that an intramolecular, not intermolecular, 
disulfide bond had been created.  Thus, it was demonstrated that Spx, like OxyR (Storz et al., 
1990), is activated by a thiol-disulfide switch at the onset of thiol-specific oxidative stress, and 
this activation is necessary for positive transcriptional regulation (Nakano et al., 2005).  By this 
mechanism Spx acts as both the sensor and transducer of oxidative stress, as was shown with 
OxyR (Storz et al., 1990).  The mechanism by which Spx activates transcription is still not clear, 
however, as DNase I footprinting revealed no DNA-binding ability of even oxidized Spx at the 
trxB promoter (Nakano et al., 2005). 
 Newberry et al. (2005) solved the crystal structure of Spx in complex with the α-CTD of 
RNAP.  Spx is composed of two domains:  a central domain which interacts with RNAP, and a 
redox domain consisting of the N- and C- termini, including the CXXC motif.  Oddly, the site of 
interaction between Spx and the α-CTD was found to be on the distal face from the redox-
sensing motif, opening up the possibility that Spx could induce a conformational change in 
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RNAP allosterically that would allow initiation of transcription.  Another surprising discovery 
was that the affinity of Spx for α was unchanged regardless of oxidation state (Newberry et al., 
2005), in agreement with other reports that reduced Spx could still bind α in footprinting 
experiments, though the complex formed was unproductive (Nakano et al., 2005) and that the 
redox domain of Spx is nonessential for repression of target genes (Zhang et al., 2006).   
Residues within the region of interaction of α with Spx correspond to residues of the E. coli α-
CTD that are necessary for transcriptional initiation by activator proteins (Chen et al., 2003), 
supporting the Spx-dependent repression model (Nakano et al., 2003b; Zhang et al., 2006).  Spx 
also interacts with residues of B. subtilis α corresponding to the “261” determinant of E. coli α, a 
necessary element for recruitment of σ70, the E. coli housekeeping σ (Savery et al., 2002), 
prompting the investigators to hypothesize that Spx could activate transcription by facilitating 
recruitment of σ to the RNAP core enzyme to form the holoenzyme (Newberry et al., 2005). 
 As clpXP mutations have such pleiotropic effects in a nonvirulent organism such as B. 
subtilis, Frees et al., (2003) investigated whether mutations of either gene could affect virulence 
in the pathogen, S. aureus.  The researchers constructed deletions of both genes in the common 
laboratory strain, 8325-4, which is the parent strain of RN6390 (Novick, 1967), and examined 
the resultant change in the overall pattern of expression of genes involved in both virulence and 
stress response.  Predictably, the stress response was dampened in the clpP mutant, particularly 
to heat shock (Frees et al., 2003), as ClpP has long been known to play a crucial role in the 
turnover of denatured and otherwise nonnative proteins (Frees and Ingmer, 1999; Krüger et al., 
2000).  The strain harboring a clpX deletion was actually more susceptible to many types of 
environmental stress, including oxidative stress by hydrogen peroxide.  If Spx accumulation is 
controlled by ClpXP in S. aureus as it is in B. subtilis, one would assume that these mutants were 
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Spx-overproducers and that they would gain oxidoreductase activity, at least in response to thiol-
specific oxidative stress.  However, the response to diamide was not examined in this study.  The 
researchers did note an attenuation of virulence in both mutants, probably by both agr-dependent 
(represented by decreased hemolysis) and agr-independent (represented by decreased spa 
transcription) pathways.  Whether these effects involve Spx is not clear (Frees et al., 2003).  
Examining the interconnectedness of virulence gene regulatory circuits involving ClpXP, agr, 
and SarA and its homologs, Frees et al., (2005) established an absolute requirement of ClpX for 
spa and sspA transcription.  They also observed repression of clfB and fnbA by both ClpX and 
ClpP, although they could not conclude that virulence gene expression was systematically 
controlled by ClpXP.  Instead they proposed that ClpXP affects virulence through molecular 
chaperone activity of other regulators, such as Rot (Frees et al., 2005).  Based on the work of the 
Zuber laboratory, Spx would surely be another candidate.   
 The same laboratory constructed a spx deletion strain of 8325-4, and examined changes 
in growth and development, stress response, and biofilm formation compared to the clp mutants 
and wild-type.  Like B. subtilis, S. aureus lacking spx is hypersensitive to diamide; unlike B. 
subtilis, S. aureus lacking spx is deficient in biosynthesis and more sensitive to other stresses like 
hydrogen peroxide, sub- and superoptimal temperatures, and increased osmotic pressure.  
Although S. aureus Spx accumulates in a clp background,  indicating it is likely a substrate for 
ClpXP, transcription seems to be autoregulated in S. aureus, and induction of stress response by 
Spx is not accompanied by increased spx transcription (Pamp et al., 2006) as Peter Zuber’s group 
found in B. subtilis (Nakano et al., 2003a).  Spx in S. aureus appears to be an important 
housekeeping gene, unlike Spx in B. subtilis; this may be because trxB is essential in S. aureus 
even under non-oxidizing conditions (Uziel et al., 2004), and its two promoters are both 
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dependent on Spx and σA (Pamp et al. 2006).  In B. subtilis, trxB transcription is activated by 
either σB or σA and Spx (Nakano et al., 2005).  Most interestingly, the spx mutant had greatly 
enhanced ability to form a biofilm compared to wild-type, even without biofilm-promoting 
additives to the media.  The researchers concluded that Spx negatively impacts biofilm 
production by modulating the expression of icaR, a repressor of the ica operon, which encodes 
gene products necessary for the synthesis of polysaccharide intercellular adhesin (PIA) (Cramton 
et al., 1999).  It is fairly obvious, even from this rather preliminary study, that regulatory events 
by Spx from S. aureus are not identical to those by Spx from B. subtilis.  This may be due, at 
least in part, to its role within the complex layer of regulatory circuits promoting virulence in S. 
aureus. 
 In this study, we have cloned spx from S. aureus laboratory strain RN6390, 
overexpressed it in E. coli, and purified the recombinant protein.  We also isolated Spx in the 
form of inclusion bodies, and used these for production of polyclonal antibodies in rabbits for 
western analysis of purified Spx and expression of Spx in whole-cell lysates of RN6390.  We 
have partially purified the RNAP holoenzyme from RN6390, and created an S. aureus in vitro 
transcription (IVT) system for analysis of Spx-dependent activation of trxB.  These experiments 
were also performed in a B. subtilis IVT system previously described (Liu and Zuber, 2000; 
Nakano et al., 2003b; Nakano et al., 2005).  S. aureus Spx was highly active in the B. subtilis 
IVT system, stimulating transcription of trxB in the absence of a reducing agent.  Although 
active RNAP was extracted from S. aureus, the preparation had a high level of contaminating 
proteins, which may have hindered Spx activity, as Spx-dependent initiation of trxB transcription 
could not be demonstrated in the S. aureus IVT system.    
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Materials and Methods 
 
Bacterial strains and growth conditions: 
 
Escherichia coli strain One Shot TOPO 10F’ (Invitrogen) was used for TA-cloning of the spx 
gene amplified from S. aureus RN6390 genomic DNA.  E. coli strain XL1-Blue (Stratagene) was 
used for mutagenesis reactions. E. coli strain BL21 (DE3) pLysS (Novagen) was used for 
expression of recombinant Spx.   E. coli strain DH5α was used for all other sub-cloning reactions 
and storage of all plasmids.  All E. coli strains except BL21 (DE3) pLysS were grown in Luria-
Bertani (LB) media at 37 °C with shaking at 225 rpm.  For soluble expression of Spx in BL21 
(DE3) pLys, cells were grown in Terrific Broth supplemented with 1 M D-sorbitol and 10 mM 
betaine HCl at 25 °C while shaking at 150 rpm.  For expression of Spx in inclusion bodies for 
antibody production, BL21 (DE3) pLys cells were grown as other E. coli strains.  For selection 
of transformants with TOPO 10F’ and pET9a vectors, kanamycin (Km) was added to the media 
at a concentration of 25 µg mL-1.  For selection of pLysS in BL21 (DE3) pLysS, 
chloramphenicol (Cm) was added to a concentration of 30 µg mL-1.  For selection of 
transformants with pLL28 in E. coli, spectinomycin (Sm) was added to the media at a 
concentration of 50 µg mL-1.  S. aureus strain RN6390 was used for partial purification of RNA 
polymerase and extraction of genomic DNA.  S. aureus cells were grown in brain-heart infusion 
(BHI) (Bacto) or tryptic soy broth (TSB) (Bacto) at 37 °C with shaking at 225 rpm and without 
antibiotic selection.  All strains were stored at -80 °C in growth media with dimethylsufoxide 
(DMSO) added to a final concentration of 7 % and antibiotics where necessary. 
Purification of genomic DNA: 
 
2 mL of an overnight culture of S. aureus strain RN6390 was pelleted at 6000 g for 5 minutes 
and resuspended in 500 µL cold P1 buffer (50 mM Tris-Cl, pH 8.0, 10 mM EDTA) with 100 µg 
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RNase A, 200 µg Proteinase K, and 20 µg lysostaphin.  The lysate was incubated at 37 °C until 
the solution became clear.  Phenol extractions were performed with 500 µL phenol equilibrated 
to a pH of 8.0 until the interface between organic and aqueous layers was clear.  Phenol was 
removed from solution by chloroform extractions performed likewise.  For all extractions, the 
solution was centrifuged for 5 minutes at 15,000 rpm, and the organic layer was discarded.  DNA 
was subsequently precipitated with 1/10 volume 3 M sodium acetate, pH 5.2, and ¾ volume neat 
isopropanol, and the solution was centrifuged for 20 minutes at 15,000 rpm, 4 °C.  The pellet 
was washed once with 1 mL ice-cold 70 % ethanol, centrifuged for 5 minutes at 15,000 rpm, 
4 °C, and dried in a 37 °C incubator.  DNA was dissolved in 100 µL EB buffer (10 mM Tris-Cl, 
pH 8.5) overnight at room temperature.  
Preparation of plasmid DNA: 
Plasmid DNA was purified with the Qiagen miniprep and midiprep kits (Qiagen, Inc.) according 
to manufacturer’s instructions. 
Construction of Spx expression vector: 
The Spx coding region was amplified from S. aureus genomic DNA by PCR using primers 
oJKM1 and oJKM2, which incorporated Nde I and Bam H1 restriction sites, respectively.  The 
PCR product was visualized by agarose gel electrophoresis to verify that a product of the correct 
size (approximately 400 bp) had been amplified (results not shown).   The PCR product was TA-
cloned into pCR 2.1-TOPO vector (Invitrogen) according to manufacturer’s instructions to make 
pJKM10.  The Spx coding region was excised from the vector by sequential restriction 
digestions with Nde I and Bam H1 enzymes (New England BioLabs) followed by agarose gel 
electrophoresis.  The band corresponding to Spx was excised from the gel and purified with the 
QIAEX II kit (Qiagen) according to manufacturer’s instructions.  Purified insert was ligated into 
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pET9a expression vector (Novagen) cut with the same enzymes with 1 µL T4 DNA ligase (400 
U µL-1) (New England BioLabs) to make pJKM11.  The correct nucleotide sequence of the 
recombinant gene was confirmed by DNA sequencing (University of Arkansas for Medical 
Sciences, Little Rock, AR).  
Overexpression and purification of Spx: 
 
Expression host BL21 (DE3) pLysS was transformed with pJKM11 and grown up in 5 mL LB-
Km-Cm media overnight at 37 °C.  The entire overnight culture was then used to inoculate 500 
mL Terrific Broth containing 1 M D-sorbitol and 10 mM betaine and appropriate antibiotics.  
Cells were grown in 2 L baffled polycarbonate flasks at 25 °C with shaking until the cell density 
reached an OD600 of 0.4.  Spx overexpression was induced by adding 1 mM isopropy-β-D-
thiogalactopyranoside (IPTG), and the cells were grown an additional 24 hours.  Cells were 
harvested by centrifugation for 10 minutes at 5000 rpm, 4 °C, and pellets were frozen at -20 ºC.  
Cells were thawed in 5 mL ice-cold MDJ-50 buffer (50 mM Tris-Cl pH 6.9, 50 mM NaCl, 1 mM 
EDTA, 1 mM DTT, and 1 mM phenylmethylsulfonyl fluoride (PMSF)) per gram of wet cell 
paste on ice.  Cell lysis was achieved by the release of endogenous lysozyme encoded within the 
pLysS plasmid carried by the expression host.  Chromosomal DNA was sheared by sonication at 
30 % power in 15 second intervals until the lysate lost viscosity.  The lysate was cleared by 
centrifugation for 20 minutes at 14,000 rpm, 4 °C.  The supernatant was brought to 55 % of 
saturation with solid ammonium sulfate at a rate of 5 g hr-1 while stirring in 4 °C with an 
additional hour of stirring, and centrifuged at 10,000 rpm for 10 minutes, 4 °C.  The insoluble 
fraction was discarded, and the supernatant was brought to 70 % of saturation the same way.  
This precipitate was resuspended in 8.5 mL cold MDJ-50 buffer, centrifuged again to remove 
insoluble particulates, and desalted into 12 mL of the same buffer with an Econo-Pac 10 DG 
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chromatography column (BioRad) in three-3 mL batches according to manufacturer’s 
instructions.  The desalted solution (12 mL) was applied to a Macro-Prep High S exchange 
support column (BioRad).  The column was washed first with MDJ-50 buffer until the OD280 of 
the wash fell below 0.02, and then washed with MDJ-100 buffer (same buffer with 100 mM 
NaCl) the same way.  Spx was eluted from the column with MDJ-200 buffer and the column was 
cleared with 15 mL MDJ-1000 buffer.  10 µL of each fraction was mixed with an equal volume 
of sample buffer, boiled at 95 °C for 5 minutes, and analyzed by 15 % Tricine sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by staining with Coomassie 
Brilliant Blue R-250 (Figure 1).  The Spx-containing fraction was desalted on an Econo-Pac 10 
DG chromatography column into MDJ-50 buffer, and stored in small aliquots at -20 °C with 
glycerol added to a final concentration of 10 %.  The purity of Spx was estimated to be over 
99 %, with an average concentration of 0.5 – 1 mg mL-1, as determined via the Coomassie assay 
(Pierce) against bovine serum albumin (BSA) standards and spectrophotometric measurement at 
280 nm using an extinction co-efficient of 10,870.  The identity of the protein was verified by 
western blot analysis and automated Edman degradation of the NH2-terminal ten amino acids 
(University of Louisiana Health and Sciences Core Labs, New Orleans, La). 
Polyclonal anti-Spx antibody production and western blots: 
Recombinant Spx was expressed as described above except that cells were grown in 500 mL LB 
media with antibiotics at 37 ºC, and induced with 1 mM IPTG for 3 hours.    When cells were 
cultured this way, Spx was found in the insoluble fraction of the lysate, likely in inclusion bodies.  
An inclusion body isolation was performed for antibody production.  Cells were harvested by 
centrifugation at 5000 rpm for 10 minutes, 4 °C, and frozen at -20 °C.  The pellet was 
resuspended in lysis buffer (50 mM Tris-Cl pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 mM DTT) at 
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room temperature for 20 min, and centrifuged at 5000 rpm for 10 minutes, 4 °C.  The 
spheroplasts were resuspended in 10 mL of the same lysis buffer with 0.1 % sodium 
deoxycholate and incubated on ice.  8 mM MgCl2 and 100 µg DNase I were added at 4 ºC.  The 
inclusion bodies were removed by centrifugation, and washed twice with 10 mL lysis buffer plus 
1 % Triton-X.  The resultant pellet was dissolved in 2.5 mL of Tricine sample buffer, and boiled 
at 95 ºC for 10 min.  The entire sample was loaded onto a 15 % Tricine SDS-polyacrylamide gel, 
and resolved by electrophoresis.  A vertical strip of the gel was stained with Coomassie Brilliant 
Blue R-250 and aligned with the gel to reveal the location of Spx, which was excised from the 
gel, and sent to Sigma Aldrich for injection into each of two rabbits.  The rabbits were injected 
with the homogenate three times at two-week intervals, and given an additional booster five days 
prior to the final bleed.  The serum from the rabbits was used as the primary antibody in 
immunoblotting with no further modifications.  Purified Spx was resolved by SDS-PAGE, and 
transferred onto a polyvinylidene difluoride membrane (PVDF) overnight at 20 V in 4 °C in 
Towbin solution (25 mM Tris, 192 mM glycine, 20 % methanol).  After blocking non-specific 
binding with a 10 % powdered milk phosphate-buffered saline solution with 0.05 % Tween-20 
(PBST), the membrane was incubated with anti-Spx primary antibody diluted 1:5000 in PBST 
containing 1 % powdered milk.  Secondary antibody was goat anti-rabbit linked with horseradish 
peroxidase (Amersham) diluted 1:100,000.  Antibodies were detected with substrates from the 
ECL kit (Amersham) used according to manufacturer’s instructions, and scanned on the 
Amersham Biosciences Storm 840 scanner (Figure 2).   
Site-directed mutagenesis of Spx:  
pJKM11 was used as the template for PCR with the Quick Change site-directed mutagenesis kit 
(Stratagene).  oJKM3 and oJKM4 introduced a C10A mutation in pJKM11 to make pJKM12.  
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oJKM5 and oJKM6 created a C13A mutation to make pJKM13.  oJKM7 and oJKM8 mutated 
both residues, resulting in a C10/13A change in pJKM14.  All reactions were performed 
according to manufacturer’s instructions for one amino acid change reactions (16 PCR cycles), 
followed by Dpn I digestion of methylated parental template.  Reactions were subsequently 
purified with the Qiagen PCR Clean-Up kit (Qiagen, Inc.), and used to transform E. coli XL1-
Blue supercompetent cells (Stratagene).  Nucleotide changes were verified by DNA sequencing.  
BL21 (DE3) pLysS expression host was transformed by mutant vectors, and expression of 
mutant alleles of Spx was attempted using the same protocol as for wild-type Spx (Figure 3).  
Partial purification of RNA polymerase holoenzyme from S. aureus and western blots: 
4  mL of an overnight culture of RN6390 grown in BHI were used to inoculate 4 x 1 L BHI broth 
pre-warmed to 37 °C, which was grown at  37 °C on 225 rpm until cells reached late log phase 
(OD560 = 1.2).  Cells were harvested by centrifugation at 3500 rpm for 10 minutes, 4 °C, and 
frozen at -80 °C overnight.  Cells were thawed on ice in 30 mL cold lysis buffer (50 mM Tris pH 
7.8, 100 mM NaCl, 5 mM MgCl2, 20 % glycerol, 5 mM β-mercaptoethanol) for 30 minutes, and 
resuspended by vortexing.  PMSF was added to a final concentration of 1 mM, and cells were 
lysed by passing through a French pressure cell press three times at 10,000 psi.  The lysate was 
cleared by centrifugation at 14,000 rpm for 20 minutes, 4 °C.  The cleared lysate was brought to 
30 % of saturation with ammonium sulfate, and the resultant pellet was brought to 60 % of 
saturation, as stated previously.  This pellet was resuspended in 9 mL lysis buffer and dialyzed 
overnight in 1 L lysis buffer in 4 °C using a Slide-A-Lyzer dialysis cassette with 7,000 MWCO 
(Pierce.)  The dialyzed sample was centrifuged at 14,000 rpm for 10 minutes, 4 °C to clear it of 
insoluble particulates, and loaded onto a heparin-Sepharose column at the rate of 1 mL min-1.  
The column was washed with at least 50 mL of lysis buffer, and proteins were eluted with a 90 
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mL linear gradient of lysis buffer containing 100 mM – 1 M NaCl.  Column fractions were 
analyzed for the presence of β and β’ subunits of RNA polymerase by 12 % SDS-PAGE and 
peak fractions were combined.  The molarity of NaCl in pooled fractions was calculated, and the 
solution was diluted to 100 mM NaCl with lysis buffer containing no salt.  The diluted solution 
was applied to an Econo-Pac High Q Strong Anion exchange column (BioRad) at a rate of 2 mL 
min-1.  Proteins were eluted with a linear gradient performed and analyzed as before.  Peak 
fractions were combined and concentrated in a Centricon Y-10 (Ambion) at 5000 rpm, 4 °C until 
volume ≤ 50 µL.  Buffer exchange was performed in the concentrator with 1 mL storage buffer 
(10 mM Tris pH 8.0, 10 mM MgCl2, 100 mM KCl, 0.1 mM EDTA, 20 % glycerol) and 
concentrated to about 50 µL.  Neat glycerol was added to a final concentration of 50 %, and the 
enzyme was stored at -20 °C.  Protein concentration was determined via the Coomassie assay 
(BioRad) according to manufacturer’s instructions.  Western analysis was performed on 
concentrated heparin fractions and dialyzed ammonium sulfate pellet with polyclonal antibody 
raised against purified α subunit from B. subtilis (results not shown) and on concentrated High-Q 
fractions with anti-Spx from S. aureus generated as described previously (Figure 5).  Anti-α was 
diluted 1:1000, and secondary antibody, goat anti-rabbit alkaline phosphatase (BioRad), was 
used at a dilution of 1:30,000.  Anti-Spx was diluted 1:2000.  Reactions were developed in 
alkaline phosphatase (AP) color development solution, and AP conjugate substrate was added 
according to manufacturer’s instructions (BioRad). 
In vitro transcription of rpsD and trxB: 
Linear DNA templates for in vitro transcription (IVT) were generated by PCR from RN6390 
genomic DNA.  oJKM9 and oJKM10 amplified a 305 bp fragment including promoters for rpsD, 
which encodes a 129 nt major run-off transcript and a 93 nt minor transcript.  A 228 bp fragment 
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with trxB promoter elements amplified by oJKM10 and oJKM11 encodes a 91 nt run-off 
transcript (Uziel et al., 2004).  IVT was performed as previously described (Nakano et al., 2005).  
Briefly, IVT reactions (20 µL) using B. subtilis RNAP contained 10 mM Tris pH 8.0, 50 mM 
NaCl, 5 mM MgCl2, 50 µg mL-1 BSA, 50 nM Spx-free RNAP, 100 nM purified B. subtilis σA, 
and 20 nM rpsD or 10 nM trxB in diethylpyrocarbonate (DEPC) water.  Reactions catalyzed by 
RNAP from S. aureus (approximately 50 nM) were the same but excluded σA.  Reactions were 
incubated in the presence or absence of 300 nM Spx from S. aureus or B. subtilis and/or 5 mM 
DTT for five minutes at room temperature to allow open-complex formation.  A ribonucleotide 
cocktail (200 µM each GTP, ATP, and CTP, 250 µM UTP, and 5 µCi [α-32P]UTP) was added to 
the reaction, which was incubated at 37 °C to initiate transcription.  After 20 minutes, the 
reactions were precipitated with 2.5 volumes of ice-cold absolute ethanol and 1/10 volume of 5 
M ammonium acetate at -20 °C for 30 minutes, and then centrifuged at 14,000 rpm for 20 
minutes.  Precipitated pellets were resuspended in 5 µL formamide loading dye, boiled at 90 °C 
for three minutes, and resolved by denaturing electrophoresis through a 7.6 M urea 8 % 
polyacrylamide gel at 550 V.  Transcripts were visualized by storage phosphorimaging and 
scanned on a phosphorimager (BioRad).   
Construction of E. coli-S. aureus shuttle vector to make spx::cat mutant: 
spx locus (spx gene with two flanking genes, mecA and trpS) was amplified by PCR from 
RN6390 genomic DNA using oJKM13 and oJKM14.  The PCR product of approximately 2.9 kb 
was precipitated with ethanol, resolved by agarose gel electrophoresis, and excised from the gel.  
DNA was purified from the agarose using the QIAEX II kit, and TA-cloned into pCR 2.1-TOPO 
to make pJKM20, which was then used to transform TOPO One Shot competent cells.  Plasmid 
DNA was purified, and the presence of an insert was verified by restriction digest and 
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sequencing.  pJKM20 was used as the template for PCR with oJKM15 and oJKM16, which  
amplified trpS, incorporating Sac I and Not I restriction sites, and with oJKM17 and oJKM18, 
which amplified mecA, adding in Bam H1 and Hind III sites.  PCR products (the former of 1.6 
kb and the latter being 1.3 kb in size) were cloned into pCR 2.1-TOPO as stated above, to make 
pJKM21 and pJKM22, respectively.  trpS was separated from the vector by sequential digestion 
with Not I followed by Sac I, and the product was resolved on 0.7 % low melting-point agarose 
gel.  E. coli-S. aureus shuttle vector, pLL28, was digested likewise, and electophoresed 
alongside trpS.  The two bands (trpS and linearized pLL28) were excised from the gel, placed in 
separate microcentrifuge tubes, heated to 65 °C for ten minutes, and then removed to 37 °C 
heating block.  10 µL of each dissolved gel plug was used in a 50 µL ligation reaction, which 
included 5 µL 10 X T4 DNA ligase buffer and 25 µL 10 mM Tris, pH 7.6 at 37 °C.  1 µ T4 DNA 
ligase was added to the mixture while vortexing.  The reaction was incubated overnight at room 
temperature, stopped at 65 °C for ten minutes, and removed to a 37 °C heating block. 10µL of 
the ligation product, pJKM23, was used to transform 100 µL E. coli strain DH5α.  Plasmid DNA 
was purified from an overnight culture of a transformant by miniprep.  mecA was sequentially 
digested from pCR 2.1-TOPO with Bam H1 followed by Hind III, and ligated into pJKM23 cut 
with the same enzymes using the protocol stated above to make pJKM24.  Presence of all inserts 
was verified by visualization by gel electrophoresis followed by staining with ethidium bromide 
and restriction digest.  pJKM30 was made like pJKM21 except that oJKM15 and oJKM16 were 
used for PCR, which amplified nucleotides 1-163 from the 5’ end of spx along with trpS.  
pJKM31 was made likewise, with PCR of pJKM21 amplifying the 3’ end of spx encompassing 
nucleotides 250-396 along with mecA.  The insert was digested from pJKM31 and ligated into 
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pJKM30 to make pJKM32.  All restriction enzymes and buffers were purchased from New 
England BioLabs. 
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Results  
Purification of RN6390 genomic DNA: 
Genomic DNA was extracted from S. aureus strain RN6390 in order to amplify the gene 
encoding Spx to clone into an expression vector and to amplify its flanking genes, trpS and mecA, 
for the purpose of creating a vector to delete chromosomal spx.  A typical extraction from a 2 mL 
overnight culture yielded approximately 20 µg of purified DNA as determined via 
spectrophotometric measurement of OD260 using an extinction co-efficient of 50 µg mL-1.  
Quality was judged by the ratio of OD260:OD280, which was typically around 1.9, and also by an 
OD220 to OD280 spectrophotometric wavelength scan, which showed very low levels of RNA and 
protein contamination (results not shown).  DNA was also visually inspected by agarose gel 
electrophoresis followed by staining with ethidium bromide, and fidelity of DNA was checked 
by using it as the template for PCR with oJKM1 and oJKM2, which generated a product of the 
correct size (results not shown).  Although this yield is rather low, the high quality of DNA 
extracted indicates the protocol used was fairly efficient.   
Soluble expression and purification of wild-type Spx: 
Spx was expressed in recombinant form without any heterologous tags or fusions and purified to 
use in IVT of redox genes in order to characterize its transcriptional activity in S. aureus.  For 
overexpression of recombinant S. aureus Spx, the highly efficient bacteriophage T7 RNAP 
encoded within the genome of E. coli expression host was utilized.   Induction of protein 
expression was accomplished by the addition of 1 mM IPTG after cells reached mid-exponential 
growth (OD600 = 0.4), to activate expression of T7 RNAP under control of lacI.  Cells were 
autolysed by endogenously-expressed lysozyme encoded in the pLysS plasmid carried by the 
expression host, which was released by the slow freeze-thaw method.  When the expression host 
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carrying pJKM11 was cultured in LB broth at 37 °C, overexpressed Spx was found in the 
insoluble fraction of the lysate, likely in inclusion bodies (Figure 1, Lanes 1-2).  Solubility 
problems were surmounted by growing the cells under osmotic shock conditions in 1 M D-
sorbitol with 10 mM betaine at 25 °C (Blackwell and Horgan, 1991).  When cells were grown 
under these conditions, Spx was almost completely soluble in the cleared lysate (Figure 1, 
Lanes 3-4).  Spx was then purified by a two-step ammonium sulfate precipitation followed by 
ion exchange chromatography.  The cleared lysate was brought to 55 % of saturation with 
ammonium sulfate and pelleted, and this pellet was then brought to 70 % of saturation.  This first 
separation step rid the preparation of approximately 70 % of contaminating proteins.  The 
desalted 70 % pellet was bound to the High S-strong cation exchange chromatography column.  
At a pH of 6.9, most of the remaining proteins in the E. coli lysate were apparently negatively-
charged:  they did not bind to or bound very weakly to the column, nearly all the contaminants 
being discarded in the flow-through or initial wash (Figure 1, lanes 8-9).  The wash with buffer 
containing 200 mM NaCl eluted Spx of apparent homogeneity, resulting in a single band which 
migrated to 15 kDa as seen by SDS-PAGE, in agreement with the published molecular weight of 
Spx (15.4 kDa) (Nakano et al., 2001) (Figure 1, lane 11).  Some Spx remained bound to the 
High S column, as evidenced by stripping the column of all remaining bound proteins with 
buffer containing 1 M NaCl (Figure 1, lane 12), but the protocol was still deemed quite efficient.  
Raising the salt concentration of the elution buffer would increase the likelihood of 
contamination by proteins that came off in the final wash, as seen by SDS-PAGE.  A typical 
yield of active Spx was 3 – 5 mg liter of culture -1.  The identity of the purified protein was 
confirmed by sequencing of the ten NH2-terminal residues via automated Edman degradation  
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Figure 1:  Soluble expression and purification of recombinant Spx 
 
SDS-PAGE:  (10 µL of each sample) 
Lane M:  Full-Range Rainbow molecular weight marker (Amersham); Lane 1: Insoluble fraction 
of lysate from culture grown in LB at 37 °C;  Lane 2:  Soluble supernatant of same culture;  Lane 
3:  Insoluble fraction of lysate from culture grown in Terrific Broth with 1 M D-sorbitol and 10 
mM betaine at 25 °C;  Lane 4:  Soluble supernatant of same culture;  Lane 5:  55 % ammonium 
sulfate precipitate;  Lane 6:  70 % ammonium sulfate precipitate;  Lane 7:  Desalted 70 % 
ammonium sulfate precipitate;  Lane 8:  High-S column flow-through;  Lane 9:  High-S 50 mM 
NaCl wash;  Lane 10:  High-S 100 mM NaCl wash;  Lane 11:  High-S 200 mM NaCl wash;  
Lane 12:  High-S 1 M NaCl elution buffer 
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 (data not shown) and immunoblotting with polyclonal antibodies raised against purified Spx 
(Figure 2).  Spx is 131 amino acids in length, and has a predicted isoelectric point (pI) of 6.13. 
Expression of mutant alleles of Spx: 
To better elucidate the mechanism by which Spx activates transcription of redox genes, we 
mutated the CXXC region within Spx which comprises the redox domain essential for its 
activation activity, mutating each cysteine residue both singly and concertedly.  The Quick 
Change site-directed mutagenesis kit (Stratagene) was used to mutate the spx coding region in 
pJKM11 to construct pJKM12, pJKM13, and pJKM14.  Each or both of the two cysteine 
residues in Spx was changed to an alanine (C10A in pJKM12, C13A in pJKM13, and C10/13A 
in pJKM14).  Each of the pET9a constructs expressing mutant alleles of Spx was used to 
transform expression host, BL21 (DE3) pLysS.  Expression of the mutant Spx alleles was 
attempted using the same protocol as for wild-type Spx:  slow growth at room temperature in 
osmotic shock conditions (1 M D-sorbitol and 10 mM betaine) (Blackwell and Horgan, 1999) 
followed by induction of protein expression with 1 mM IPTG.  The frozen cell pellets were 
autolysed and sonicated as stated for wild-type Spx.  The lysate was cleared by centrifugation, 
and aliquots of the soluble supernatant and insoluble pellet were analyzed by 15 % Tricine SDS-
PAGE (Figure 3).  All three mutant alleles of Spx were expressed entirely in insoluble form, 
likely in inclusion bodies.  Repeated attempts to express the mutant proteins did not result in 
soluble expression of any of the C to A mutants. 
Partial purification of RNA polymerase holoenzyme from S. aureus: 
To catalyze Spx-dependent IVT of redox genes, crude preparation of DNA-dependent RNA 
polymerase (RNAP) was made from wild-type S. aureus RN6390 cell cultures.  Due to its 
magnitude in size (437 kDa) (Deora and Misra, 1995) and number of subunits (five), RNA  
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Figure 2:  Western blot of purified Spx with anti-Spx antibody 
 
Lane 1: 1 µg purified Spx   Lane M:  Magic-Mark molecular weight marker (Invitrogen)  
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 Figure 3:  Expression of mutant alleles of Spx was insoluble  
SDS-PAGE:  (15 µL of each sample) 
Lane M:  Full Range Rainbow molecular weight marker (Amersham); Lane 1:  Insoluble fraction 
of lysate from cells expressing C10A allele of Spx;  Lane 2:  Soluble supernatant of same 
culture;  Lane 3:  Insoluble fraction of lysate from cells expressing C13A allele of Spx;  Lane 4:  
Soluble supernatant of same culture;  Lane 5:  Insoluble fraction of lysate from cells expressing 
C10/13A double mutant allele of Spx;  Lane 6:  Soluble supernatant of same culture 
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polymerase cannot be easily overexpressed in recombinant form using the T7 polymerase system 
in E. coli, as was employed for Spx overexpression.  There was also no readily available assay 
for RNAP activity with which to identify purified fractions of polymerase, although one has been 
published (Deora and Misra, 1995).  No antibodies to any of the four different subunits (α, β, β’, 
or σ) were obtained, except one to B. subtilis α which proved unreactive in western blots (results 
not shown). Therefore, visual inspection of SDS polyacrylamide gels for the presence of β and β’ 
subunits from all of the various fractions collected was the only indicator of the efficacy of this 
highly empirical protocol.  S. aureus β and β’ have been reported to migrate to 151 and 147 kDa, 
respectively, by SDS-PAGE (Deora and Misra, 1995).  As they are among the largest proteins 
found in the prokaryotic proteasome, they are readily identifiable.  S. aureus α (42 kDa) and σ 
(55 kDa) (Deora and Misra, 1995) are not as easily apparent on gels, as more contaminating 
proteins will be found in this moderately-sized region.  α and σ subunits also often show aberrant 
mobility in SDS-PAGE (Losick et al., 1970; Lowe et al., 1979).  Cells were grown until their 
approximate entry into late-exponential growth (OD560 = 1.2) to ensure that protein quantity 
would be sufficient, but to minimize the likelihood of isolating RNAP with σB or other alternate 
sigma factors associated with stress response (Peter Zuber, personal communication).  After 
harvesting, cell pellets were frozen overnight at -80 °C, and then lysed by passage through a 
French pressure cell press as stated in Materials and Methods.  The first purification step 
employed was precipitation with ammonium sulfate.  The initial cut was to 30 % of saturation 
(results not shown), and the supernatant was subsequently brought to 60 % of saturation, and 
centrifuged.  The insoluble fraction of the 60 % saturated lysate was used for further purification 
(Figure 4, Lane 2) after dialysis to remove salt.  Previously, the soluble supernatant of the 60 % 
fraction had been brought to 80 % of saturation with ammonium sulfate (results not shown).   
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Figure 4:  Partial purification of RNA polymerase from Staphylococcus aureus 
 
Lane M:  Broad-range molecular weight marker (BioRad)  Lane 1:  Purified 6-His-tagged B. 
subtilis RNAP;  Lane 2:  60 % ammonium sulfate precipitate of cleared lysate;  Lane 3:  
Heparin-Sepharose column flow-through;  Lane 4:  Heparin 100 mM NaCl wash;  Lane 5:  
Heparin combined peak fractions  Lane 6:  Heparin concentrated peak fractions  Lane 7:  High-Q 
column flow-through  Lane 8:  High-Q combined peak fractions;  Lane 9:  High-Q concentrated 
peak fractions  
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However, visual inspection of electrophoresed ammonium sulfate fractions did not 
unambiguously reveal purified or enriched β and β’ subunits due to the amount of proteins 
present.  As the 60 % precipitate contained most of the protein in the lysate (Figure 4, Lane 2), 
this was the fraction chosen for subsequent purification.  The next purification step employed 
was binding of the dialyzed 60 % precipitate to a heparin-sepharose column, and elution with a 
0.1 – 1 M NaCl gradient.  The heparin-sepharose resin consists of a weak cation exchanger with 
an affinity ligand, and is routinely used for RNA polymerase preparations (Deora and Misra, 
1995; Babcock et al., 1997), though RNA polymerase from heterologous organisms does not 
uniformly bind this column (Mani et al., 2006).  β and β’ subunits were easily seen on SDS 
polyacrylamide gels, as the heparin column chromatography was a much more effective isolation 
step than ammonium sulfate precipitation (Figure 4, Lane 5).  However, the salt concentration 
of the fractions where RNA polymerase eluted was highly variable over the three attempts 
undertaken to extract it.  In two of the trials, the fractions which eluted at a NaCl concentration 
of around 0.85 – 0.95 M were chosen (results not shown); in the other trial, the polymerase 
eluted around 0.35 M NaCl (Figure 4, Lane 5).  As the latter produced the most homogeneous 
preparation, this is the one represented in figures.  The only published protocol of S. aureus RNA 
polymerase purification reported elution from the heparin-sepharose column at a KCl 
concentration of 0.4 – 0.55 M, but this protocol did not involve initial precipitation with 
ammonium sulfate (Deora and Misra, 1995).  Likely, dialysis did not result in a uniform starting 
salt concentration among the three trials, and this led to the wide discrepancy in salt 
concentrations of elution buffers. However, this was still the most effective purification step, as 
it rid the preparation of approximately 90 % of contaminating proteins.  The final purification 
step involved binding to the High Q Strong Anion exchanger after dilution of the heparin elutate 
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to a NaCl concentration of 0.1 M with salt-free lysis buffer.  Bound proteins were eluted with a 
linear gradient of 0.1 – 1 M NaCl as before.  Fractions containing the β and β’ subunits eluted at 
NaCl concentrations between 0.45 – 0.6 M, and were combined (Figure 4, Lane 8).  This step 
initially seemed to increase the purity of the preparation (Figure 4, compare Lane 5 to Lane 8), 
but comparison of concentrated and combined heparin fractions (Figure 4, Lane 6) to the 
concentrated and combined Q fractions (Figure 4, Lane 9) shows that the Q column 
chromatography only rid the preparation of an estimated 10 - 20 % of contaminating proteins.  
Moreover, the Q column, which is highly-positively charged, binds DNA that co-purifies with 
RNA polymerase through the heparin column.  This benefit, however, is frequently 
counterbalanced by the unwanted dissociation of σ factors (Peter Zuber, personal 
communication).  The combined fractions from the Q column were concentrated and stored at -
20 °C in a buffer containing 50 % glycerol, which prevents dissociation of σ from the core 
enzyme (Burgess and Jendrisak, 1975).  The storage buffer also contained 10 mM MgCl2.  This 
is within the optimal Mg2+ concentration for activity of B. subtilis RNAP (8 – 12 mM) (Avila et 
al., 1971), although S. aureus RNAP has been reported to have maximal activity at Mg2+ 
concentration between 10 – 30 mM (Deora and Misra, 1995).  Overall, the RNA polymerase 
preparation was very successful in light of the short time available to optimize the protocol.  
Active enzyme was isolated, as evidenced by successful IVT of the rspD gene, but the protocol 
was very long, reproducibility was poor, and the yield was quite low.  Concentration of RNA 
polymerase was determined via the Bradford assay, although non-RNAP proteins may constitute 
up to 50 % of the least pure preparation.  The preparation of highest fidelity was shown to be 
quite dilute, with a concentration of approximately 0.3 µM (Figure 4, Lane 9).  A four liter 
culture only yielded enough enzyme for 22 IVT reactions from this preparation.  A second 
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preparation from a six liter culture was much more concentrated (6.2 µM), and produced enough 
RNAP to perform over 250 IVT reactions, but with an almost proportionate loss of purity (results 
not shown).   
Western analysis of partially purified S. aureus RNA polymerase: 
To ascertain if RNAP had in fact been isolated from RN6390, western detection of the α subunit 
was performed on the polymerase preparation.  A western blot was performed on an aliquot of 
the combined and concentrated heparin fractions and an aliquot of the dialyzed 60 % ammonium 
sulfate pellet from the purest S. aureus RNAP preparation (results not shown).  The primary 
antibody used was a polyclonal antibody raised against the α subunit of B. subtilis RNAP (a gift 
from Peter Zuber).  The serum was from the first bleed of the inoculated rabbit, and had never 
been tested for activity.  Concentrated 6-His-tagged B. subtilis RNAP (a gift from Peter Zuber) 
was used as a positive control.  Although the primary antibody did react with the purified RNAP 
from B. subtilis at the expected molecular weight as judged by comparison with the molecular 
weight standards, the resultant band was very weak, and did not appear for nearly one hour after 
the addition of AP substrate and conjugate.  Three bands appeared in the lane corresponding to 
the heparin fractions from the S. aureus RNAP preparation but none migrated to the expected 
weight for the α subunit of S. aureus RNAP (42 kDa) (Deora and Misra, 1995).  Multiple bands 
appeared in the lane corresponding to the dialyzed 60 % ammonium sulfate pellet, and it was 
futile to predict if any of them might represent a true reaction with the primary antibody.  More 
likely, these are the result of a cross-reaction with the goat anti-rabbit secondary antibody with 
various antigens from S. aureus, as the ammonium sulfate precipitate contained most of the 
proteins found in the S. aureus lysate.  Therefore, it proved impossible to predict from this 
experiment if RNA polymerase had in fact been extracted.  Another western blot was performed 
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on the concentrated High-Q fractions from the purest S. aureus RNAP preparation (Figure 5) 
using a polyclonal antibody raised against purified S. aureus Spx to determine if Spx co-purifies 
with S. aureus RNAP as it seems to in B. subtilis (Peter Zuber, personal communication).  
Purified Spx from B. subtilis (a gift of Peter Zuber) (Figure 5, Lane 1) and S. aureus (Figure 5, 
Lane 4) were loaded as positive controls, and both reacted with the primary antibody, producing 
a single band at the expected molecular weight (15.4 kDa).  Spx-free 6-His-tagged B. subtilis 
RNAP was loaded as a negative control, and no reaction with anti-Spx antibody was observed 
(Figure 5, Lane 2).  The concentrated High-Q fractions from the preparation of RNAP from S. 
aureus (Figure 5, Lane 3) did not react with the antibody against Spx, indicating that Spx did 
not co-purify with RNAP, at least according to the limits of detection in this experiment.     
In vitro transcription of S. aureus rpsD: 
The activity of partially purified RNAP from S. aureus was tested in a defined in vitro 
transcription system.  The rpsD gene encodes ribosomal protein S4, and its transcription has 
been shown to be unaffected by either Spx activation or repression (Nakano et al., 2003b).  It 
was therefore used as an indicator of polymerase activity and a negative control for Spx-
dependent transcriptional regulation.  The reactions were performed using a protocol optimized 
for IVT with B. subtilis RNAP (Nakano et al., 2005), which differs from published protocols 
optimized for IVT with S. aureus RNAP (Deora and Misra, 1995; Deora and Misra, 1996).  All 
reactions performed with partially purified RNAP from S. aureus were repeated with Spx-free 6-
His-tagged B. subtilis RNAP holoenzyme which was reconstituted from the core enzyme by the 
addition of purified B. subtilis σA (a gift of Peter Zuber).  To determine if the S. aureus σA 
subunit was present in the RNAP preparation, one reaction was performed where the B. subtilis 
σA subunit was added.  Based on the nucleotide sequence of the region upstream of the rpsD  
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Figure 5:  S. aureus Spx did not co-purify with RNA polymerase 
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gene, a major transcript of 129 nt and a minor transcript of 93 nt were predicted from the 305 bp 
template.  The major transcript was predicted from a perfect match to the strong B. subtilis -35 
promoter consensus sequence (TTGACA) and a near perfect match (AATAAT) to the -10 
promoter consensus sequence (TATAAT).  The elements were separated by a 17 bp linker for 
optimal RNAP recognition (Moran et al., 1982).  The minor transcript was predicted from a 
lesser match to the promoter consensus sequences:  the -35 promoter (TGTGAA) and -10 
promoter (TATATT) were separated by an 18 bp linker.  IVT of the S. aureus rpsD gene did 
result in two distinct products using both B. subtilis and S. aureus RNAP (Figure 6).  
Sequencing reactions were electrophoresed alongside the IVT reactions to verify the sizes of the 
transcripts (Fig. 6, Lanes 1-4?).  As predicted, a very strong band was seen with an approximate 
size of 130 nt based on comparison to the sequencing reactions, and a weaker band migrated to 
approximately 90 nt (Figure 6, Lane 1-4) when S. aureus RNAP was used.  The addition of 100 
nM B. subtilis σA to the S. aureus RNAP preparation produced bands of greater intensity, but of 
the same size (results not shown).   A reaction catalyzed by the B. subtilis RNAP holoenzyme 
produced the major product, but the minor product was not seen, indicating that the less perfect 
consensus promoter might not be well recognized by the polymerase from a heterologous 
organism (Helmann, 1995).  The addition of S. aureus Spx and/or DTT did not affect 
transcription of S. aureus rpsD (Figure 6, Lanes 2-4), as was observed for the B. subtilis gene 
(Nakano et al., 2005). 
In vitro transcription of S. aureus and B. subtilis trxB: 
The activation activity of Spx was tested by transcription of trxB, which is highly induced both 
in vivo and in vitro by Spx, both in B. subtilis and S. aureus, in a redox-dependent manner 
(Nakano et al., 2003a; Nakano et al., 2005; Pamp et al., 2006).  IVT was performed from the B.                           
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Figure 6:  S. aureus RNA polymerase was active in in vitro transcription of rpsD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 48
subtilis trxB template, which produces a transcript of 88 nt (a gift of Peter Zuber).  When the 6-
His-tagged B. subtilis RNAP holoenzyme catalyzed the IVT reactions, no transcription occurred 
unless S. aureus Spx was included (Figure 7, Lane 3).  Purified Spx from B. subtilis did not 
induce transcription from the B. subtilis trxB template (Figure 7, Lane 2), in contrast to previous 
findings (Nakano et al., 2005).  This failure may be due to the age of the protein preparation, or 
repeated freezing and thawing cycles it may have been exposed to.  When 5 mM DTT was added 
to the reactions, no transcription occurred whether Spx was present or not (Figure 7, Lanes 4-6).  
As the S. aureus trxB promoter had been mapped previously (Uziel et al., 2004), a 91 nt 
transcript was predicted from the 221 bp template.  B. subtilis RNAP was able to recognize the S. 
aureus promoters, and produced transcripts of the appropriate size when either B. subtilis Spx 
(Figure 7, Lane 8) or S. aureus Spx (Figure 7, Lane 9) were employed in the reactions, 
although S. aureus Spx proved to be a much stronger inducer.  Again, no transcription resulted 
without the addition of Spx (Figure 7, Lane 7) or when DTT was included (Figure 7, Lanes 10-
12).  IVT of S. aureus trxB was attempted using partially purified S. aureus RNAP.  A 
comparison of the reactions catalyzed by the two different polymerases is presented in Figure 8.  
As shown in the previous figure, a transcript was only produced by B. subtilis RNAP in the 
presence of S. aureus Spx and absence of DTT (Figure 8, Lane 2).   No obvious bands are seen 
in the reactions which employed S. aureus RNAP even in the reaction which included S. aureus 
Spx and excluded DTT (Fig. 8, Lane 6), in which a transcript was expected.  Therefore, 
although active polymerase was extracted from S. aureus as shown by the successful 
transcription of rpsD, the preparation was not faithful enough to catalyze Spx- and redox-
dependent transcription of trxB.  This may be due to other transcriptional factors that 
contaminated the RNAP preparation, or perhaps the dissociation of the σ subunit.     
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                                            1       2         3         4          5          6        7       8 
      Template (10 nM)                                   S. aureus trxB 
           RNAP (50 nM)                   B. subtilis                 S. aureus 
              Spx (300 nM)     ---      S.a.     ---       S.a.     ---       S.a.    ---     S.a. 
              DTT  (5 mM)     ---      ---        +          +       ---        ---       +       + 
                                         
Figure 7:  S. aureus Spx activates trxB in a Bacillus subtilis transcription system 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 50
                                          1      2       3      4      5       6        7       8      9     10     11     12   
          RNAP (50 nM)                                                    B. subtilis    
     Template (10 nM)                         B. subtilis trxB          S. aureus trxB 
             Spx (300 nM)   ---    B.s.   S.a.   ---    B.s.   S.a.    ---   B.s.   S.a.   ---   B.s.   S.a.     
               5 mM (DTT)   ---     ---     ---     +      +       +       ---    ---     ---     +     +      + 
                                     
Figure 8:  Spx from S. aureus, not B. subtilis, activated trxB transcription 
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Discussion  
We have expressed recombinant, native Spx and purified it to apparent homogeneity 
using a two-step ammonium sulfate precipitation followed by strong cation exchange 
chromatography.  To our knowledge, this is the first report of purification of Spx from S. aureus, 
and the first purification of native Spx from any organism.  Characterization of Spx purified 
without any tags or heterologous fusions should allow a more thorough characterization of its 
activity, as some of the preliminary data on Spx may have been compromised by artifacts of the 
6-His-tag employed for purification of various proteins.  For example, in vitro proteolysis of Spx 
could only be accomplished by ClpCP with an adaptor protein, MecA, due to the loss of the SrrA 
peptide tag-like recognition sequence on the C-terminus of 6-His-tagged Spx, while a clpC 
mutant showed no concurrent restoration of Spx accumulation (Nakano et al., 2002b).  Cloning 
the 6-His-tag onto the N-terminal of Spx permitted in vitro proteolysis by ClpXP, in accord with 
the in vivo data (Nakano et al., 2003b).  The same laboratory also used the inducible, self-
cleaving intein tag to purify Spx through a chitin column (Nakano et al., 2001).  Spx purified by 
this method was reported to bind to a complex consisting of 6-His-tagged MecA, ClpCP, and 
ComK in a protein interaction experiment performed using a pull-down assay.  Spx was thus 
initially thought to repress competence by enhancing the sequestration of ComK by ClpCP and 
MecA (Nakano et al., 2002a).  However, it was later shown that Spx represses competence by 
blocking transcriptional activation of srf by ComK (Nakano et al., 2003b).  Moreover, a yeast 
two-hybrid experiment which searched for proteins that interact with Spx only yielded positive 
clones bearing rpoA (Nakano et al., 2003b).  It is possible that Spx could have bound the Ni-
NTA column used in the pull-down assay; indeed, the researchers reported that Spx purified with 
the intein tag could bind the Ni-NTA column unless the Spx-expression host was grown in 
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copper-free media (Nakano et al., 2002a).  Although the intein tag is completely cleaved after 
purification (Chong et al., 1997), we still believe that the potential for erroneous data posed by 
these heterologous fusions outweighs the convenience of affinity purification, and that 
purification of the native protein should always be attempted unless expression of the native gene 
would prevent growth of the expression host.  Thus, the purification of native Spx reported here 
will be a valuable tool in the further study of this important protein. 
 We have reported purification of DNA-dependent RNA polymerase from S. aureus to 
approximately 50 % apparent homogeneity.  To our knowledge, this is only the second report of 
purification of native RNAP from S. aureus, and no commercial source is available.  This 
preparation was used for IVT from promoters for the rpsD and trxB genes from S. aureus.  
Although RNAP can be easily purified from B. subtilis by overexpressing a 6-His-tagged rpo 
subunit (Babcock et al., 1997; Qi and Hulett, 1998), stable transformants in S. aureus are not 
readily obtained due to the general inability of staphylococci to undergo double cross-over 
recombination (Novick, 1991).  Use of native RNAP from S. aureus should lead to a better 
understanding and more thorough characterization of its gene regulation, as RNAP from 
heterologous organisms might not recognize S. aureus-specific promoters.  Also, regulation of a 
certain gene in one organism might not involve the same factors as that of another organism, 
even if the two are closely related.  For instance, transcription of trxB in B. subtilis is activated 
by either σB alone or σA in conjunction with Spx (Nakano et al., 2005); in contrast, trxB in S. 
aureus is wholly dependent on Spx and σA (Pamp et al., 2006).   
 The RNAP preparation described in this report contains contaminating proteins when 
compared to the 6-His-tagged RNAP from B. subtilis upon polyacrylamide electrophoresis.  The 
contaminating species were of moderate size, and may be transcription factors or DNA-binding 
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accessory proteins.  The protocol used to isolate RNAP is expected to purify proteins that bind 
DNA, as the heparin column mimics the polarity and negative charges of the phosphate-ribose 
backbone of nucleic acids.  The protocol employed for RNAP purification is very similar to the 
one used to purify recombinant S. aureus SarA, a DNA-binding protein (Rechtin et al., 1999).  
Both protocols begin with ammonium sulfate precipitation.  The precipitate obtained by 60 % 
saturation was used for further purification of RNAP, whereas SarA remains soluble in a solution 
saturated to 70 % with ammonium sulfate (Rechtin et al., 1999; this report).  However, it was not 
directly tested if RNAP was completely insoluble in the solution saturated to 60 % with 
ammonium sulfate, and some of the holoenzyme might have been discarded in the supernatant.  
Likewise, SarA may be present in the 60 % ammonium sulfate precipitate of the S. aureus lysate.  
Both protocols follow the ammonium sulfate treatment with heparin column chromatography.  
Since both proteins bind DNA, they bind to the heparin column, and are eluted with a salt 
gradient (Rechtin et al., 1999; this report).  The final step in both protocols is anion exchange 
column chromatography with the High Q column.  The High Q column is strongly positively-
charged, and its purpose is essentially to remove contaminating DNA that may have co-purified 
with the DNA-binding species isolated by binding to the heparin column, as the negatively-
charged phosphate-ribose backbone in nucleic acids will bind the positively-charged resin.  Due 
to the similarity between the two protocols, it is expected that SarA may, to some extent, co-
purify with S. aureus RNAP prepared by this method.  No band migrated to the molecular weight 
of SarA (14.5 kDa) (Cheung and Projan, 1994) as seen by SDS-PAGE analysis (Fig. 4), but the 
acrylamide percentage of the gel (12 %) was likely too low to detect a protein of such small size.  
Even if a small fraction of cellular SarA co-purifies with S. aureus RNAP, its effect on IVT 
could be substantial, due to the extremely high copy number of SarA (Fujimoto et al., 
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unpublished data) and the large proportion of the transcriptome it is thought to regulate (Dunman 
et al., 2001).   
   One contaminating protein that was predicted to co-purify with S. aureus RNAP is Spx; 
Spx from B. subtilis is found in preparations of RNAP purified via the 6-His-tagged rpoC 
subunit (Peter Zuber, personal communication).  The presence of contaminating Spx in the 
holoenzyme is believed to be due to Spx’s binding to α, essentially rendering it an additional 
subunit of RNAP.  Therefore, this group purifies RNAP from a mutant strain of B. subtilis that 
lacks Spx (Peter Zuber, personal communication).  However, it seems likely that the binding of 
Spx to α would be transient, and that the stability of the complex would wane once transcription 
had been initiated or blocked.  The σ subunit, which dissociates from the core enzyme once the 
elongation stage of transcription begins, is frequently lost during purification of RNAP, and 
often has to be overexpressed and purified alone, and then added to the core enzyme to 
reconstitute the holoenzyme (Hager and Burgess, 1980; Deora and Misra, 1996).  Another 
plausible explanation for the presence of Spx in the RNAP preparation is that native Spx can, to 
some degree, bind the Ni-NTA column used to bind the 6-His-tagged β subunit, as intein-tagged 
Spx was shown to do (Nakano et al., 2002a).  A western blot was performed on the RNAP 
preparation from S. aureus described in this report using antibodies raised against Spx, and no 
Spx was detected.  However, a second preparation of RNAP was not tested for the presence of 
Spx.  When IVT was catalyzed by enzyme from this second preparation, weak transcripts were 
made from the trxB promoter whether or not Spx was included in the reaction (results not shown), 
prompting speculation that Spx had co-purified with RNAP.  Due to time constraints, the 
experiments could not be repeated to obtain reproducible results.  A probable cause of this 
discrepancy may be the transient nature of Spx’s binding to α; depending on the stringency of 
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this interaction, which itself will rely upon variable conditions such as salt, temperature, and 
protein concentration, Spx may dissociate from or co-purify with the holoenzyme.  Thus, 
different results could be obtained, which may, in part, explain the inconsistency of the data 
reported here.    
  Although the two preparations of RNAP obtained from S. aureus lysates had sufficient 
activity to catalyze IVT of the control gene, rpsD, redox- and Spx-dependent transcription of 
trxB was not successful.  The possible reasons for this failure are numerous, but the impurity of 
the holoenzyme probably plays a role in the inefficacy of these experiments.  The protocol 
employed for purification could be modified to include a final step of size-exclusion 
chromatography, as Deora and Misra (1995) utilized in their published report of S. aureus RNAP 
purification.  The authors used a size-exclusion column with a molecular weight cutoff of 200 
kDa, which should remove virtually all contaminating species, particularly since DNA-binding 
proteins tend to be rather small.  The authors followed heparin column chromatography with 
elution through a single-stranded DNA cellulose column (Deora and Misra, 1995).  This is 
expected to further enrich the solution of DNA-binding proteins, and may also aid in discarding 
double-stranded DNA that co-purified with proteins eluted from the heparin column, as the 
authors did not make use of the High Q column in this report (Deora and Misra, 1995).  A later 
report from the same laboratory purified S. aureus RNAP using a modified protocol that omitted 
the single-stranded DNA cellulose column, and added ammonium sulfate precipitation and 
strong anion exchange column chromatography through the High Q column (Deora and Misra, 
1996).  These changes render the RNAP purification protocol of Deora and Misra (1996) 
essentially identical to the one in this report, except that they included size-exclusion 
chromatography as a final step.  Since RNAP is one of the largest known prokaryotic proteins, 
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this step is expected to be quite efficient in polymerase isolation.  It is likely that if our protocol 
were modified to include size-exclusion chromatography, the resultant RNAP preparation would 
be pure enough to obtain consistent and reproducible data from IVT.  We would then expect IVT 
from the S. aureus trxB promoter to be successful if S. aureus Spx was included in the reaction 
without DTT, as we demonstrated using B. subtilis RNAP.   
Another possible explanation of our inability to show Spx-dependent transcription from 
trxB is lack of the σA subunit in the RNAP enzyme preparation, as transcription of trxB in S. 
aureus relies on the presence of both σA and Spx (Pamp et al., 2006).  However, we do not 
believe this to be true, as the rpsD gene was successfully transcribed using the same RNAP 
preparation.  When the S. aureus holoenzyme was supplemented with B. subtilis σA, the 
transcripts obtained from the rpsD promoter were of greater intensity, but the banding pattern 
was identical to that from the reaction which did not include exogenous σ factor, indicating that 
the holoenzyme had been extracted from S. aureus.  Adding B. subtilis σA to the IVT reactions 
from the trxB promoter likely would have complicated the data by adding further variables, and 
did not seem necessary.   
 Although the S. aureus RNAP preparation was not sufficiently pure to demonstrate Spx-
dependent transcription of trxB, recombinant S. aureus Spx proved to be highly active in IVT 
using B. subtilis RNAP purified via 6-His-tagged rpoC.  When 5 mM DTT was included in the 
reactions, trxB transcription was inhibited.  This finding suggests that, as was shown for B. 
subtilis Spx (Nakano et al., 2005), the activation activity of S. aureus Spx is dependent on the 
presence of a disulfide bond between cysteine residues 10 and 13.  Addition of DTT can quench 
transcriptional activation by reducing the disulfide bond to free thiol residues, as occurs with 
another redox-sensing prokaryotic transcription factor, OxyR (Storz et al., 1990).  Since the vast 
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majority of genes that Spx has been shown to positively regulate are involved in thiol 
homeostasis (Nakano et al., 2003a), it is logical that once a cell previously suffering from 
oxidative stress had returned to its normal, reduced state, transcriptional activation of target 
genes by Spx would no longer be necessary or even desirable.  The fact that cytoplasmic proteins 
rarely contain disulfide bonds due to the reducing environment of the cell (Stewart et al., 1998) 
reinforces this notion that gene regulation by Spx should be a transient reaction to cellular stress, 
since recovery from oxidative stress will be followed by Spx inactivation.                      
Spx purified from B. subtilis by a post-translationally cleaved intein tag (Nakano et al., 
2001) had little or no activity in the experiments reported here using this same B. subtilis IVT 
system to induce transcription from the trxB promoters of either B. subtilis or S. aureus.  We do 
not believe, however, that this failure to demonstrate transcriptional activation of trxB with B. 
subtilis Spx is scientifically relevant, as B. subtilis Spx purified by this method has been shown 
to be active in this IVT system, both in regards to repression and activation of target genes, 
including trxB, and other assays as well (Nakano et al., 2003b; Nakano et al., 2005; Zhang et al., 
2006).  Moreover, B. subtilis Spx from the same preparation as was used in the experiments 
reported here was found to be active at the time these experiments were performed in IVT of 
other target genes (Dindo Reyes, personal communication).  However, the preparation was 
several years old, and the specific aliquots of protein employed in the experiments reported here 
may have been subjected to repeated cycles of freezing and thawing, rendering them inactive or 
less active.  Therefore, it is our belief that the failure to show transcriptional activation of trxB by 
B. subtilis Spx in this report is either due to experimental error or reduced activity of the Spx 
preparation.  
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Since the redox-sensing activity of B. subtilis Spx is dependent on two cysteine residues 
which constitute a thiol-disulfide “switch” (Nakano et al., 2005), we attempted to express and 
purify recombinant S. aureus Spx mutants that lack one or both of these residues.  However, 
soluble expression of the three C to A Spx mutants was not achieved.  The mutant forms of Spx 
were expressed insolubly, probably as inclusion bodies, even when using the modified osmotic 
shock protocol (Blackwell and Horgan, 1991) that permitted soluble expression of wild-type Spx.  
This raises the possibility that the CXXC motif in Spx is necessary for the translated protein to 
fold into the proper conformation, since the C to A alleles of B. subtilis Spx were soluble when 
expressed as fusions (Nakano et al., 2005), and we attempted to express the mutant proteins 
without tags or fusions.  Having these mutant alleles of Spx for IVT from the trxB promoter 
could elucidate the mechanism by which the addition of DTT represses transcription, as was 
shown in B. subtilis (Nakano et al., 2005).  A possible solution to the problem presented by the 
inability to express the Spx mutants in soluble form would be to denature the insoluble protein in 
urea, and then allow it to refold into the proper conformation.  However, this avenue was not 
explored as there appeared to be no positive marker for activity of these mutant proteins to 
ensure that trxB was not transcribed in vitro due to the loss of the redox sensing motif, and not 
merely because the denatured protein was innately inactive.  But it was later shown that the 
redox sensing motif in B. subtilis Spx is inessential for its repression activity (Zhang et al., 2006).  
So it might be possible to denature the insoluble alleles of Spx and test the activity of the 
refolded protein in IVT of a gene Spx is known to repress, such as srf in B. subtilis (Nakano et 
al., 2003b).   
If repression of such a gene could be demonstrated by these refolded mutant alleles of 
Spx, then IVT from promoters of genes Spx is thought to activate based on in vivo data could be 
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attempted.  One could then form a clearer model of the redox dependence of Spx for 
transcriptional activation.  Many genes in the S. aureus transcriptome that Spx appears to 
regulate do not seem to involve redox processes; therefore, it seems likely that formation of an 
intramolecular disulfide bond may be only one mechanism by which Spx activates gene 
expression.  For example, an spx null mutant of S. aureus had enhanced biofilm formation ability, 
and this was suggested to be the result of Spx upregulating the biofilm repressor gene, icaR, 
apparently independent of oxidation state (Pamp et al., 2006).  An advantage of IVT is that the 
oxidation state of the reaction can be controlled by the addition of agents such as DTT and 
diamide.  This control is not easily achieved in vivo, where processes are more dynamic and 
conditions harder to measure.  The existence of Spx mutants that lack redox sensing ability but 
are nevertheless active could facilitate the elucidation of other mechanisms of transcriptional 
activation by Spx, if they exist. 
Another aim of this project that was not brought to fruition was the creation of an spx null 
mutant of S. aureus.  A plasmid (pJKM24) was constructed that included the genes which flank 
spx on the S. aureus chromosome, trpS and mecA, surrounding cat, which encodes 
chloramphenicol acetyltransferase, making it a marker for chloramphenicol resistance on the 
staphylococcal integration plasmid, pLL28.  It was originally intended that introduction of this 
plasmid into S. aureus laboratory strain RN6390 would result in incorporation of cat into the 
chromosome at the site of spx following double cross-over recombination events between the 
genes flanking spx on plasmid and chromosome.  However, another laboratory reported this 
event to be extremely rare (Mark Smeltzer, personal communication), which agrees with the 
overall consensus that double cross-over recombination is inefficient or nonexistent in 
staphylococci (Novick, 1991).  Another plasmid (pJKM33) was then constructed in the same 
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way except that the 5’ and 3’ ends of spx flanked the cat gene along with trpS and mecA.  This 
new vector can knock out spx on the chromosome by single cross-over recombination events 
followed by excision of the plasmid (Mark Smeltzer, personal communication).  Due to time 
constraints and the difficulty of transforming staphylococci, the mutant strain of S. aureus was 
not made.  However, another laboratory recently published a report of a creation of an spx null 
mutant of 8325-4 (Pamp et al., 2006), and has offered to share the clone with our group.  This 
mutant strain could be used in the future to inoculate mice to determine whether Spx contributes, 
either positively or negatively, to virulence in S. aureus.  We would also like to create a sar spx 
double mutant and investigate whether these two important global regulators have a synergistic 
or antagonistic effect upon each other. 
  Some evidence exists that, at least in regards to biofilm production, Spx might attenuate 
virulence, and this activity is in opposition to biofilm promotion by SarA.  Spx in S. aureus was 
found to repress biofilm formation by upregulating transcription of icaR (Pamp et al., 2006), a 
repressor of the ica operon, which encodes the enzymes necessary for the synthesis of the 
polysaccharide intracellular adhesin (PIA) (Cramton et al., 1999).  An earlier report postulated 
that SarA promotes biofilm formation by activation of ica, and that σB might antagonize SarA-
dependent biofilm development.  The authors speculated that SarA and σB were indirectly 
affecting ica expression, and that another regulator was involved, which would repress ica in a 
σB-dependent manner or activate it through SarA (Valle et al., 2003).  Biofilm factor expression 
is difficult to characterize because so many factors contribute to its regulation:  global regulators, 
cell density, media additives such as glucose and antibiotics, and environmental cues like 
osmolarity, temperature, and redox.  In a global analysis of changes in the S. aureus 
transcriptome in response to hydrogen peroxide, Chang et al. (2006) noted a halt in ica 
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transcription.  Based on the later report by Pamp et al. (2006), Spx may be responsible for this 
oxidative stress-induced repression of ica, by activation of icaR.  In light of this evidence, Spx 
appears to be yet another regulator in what is clearly a complex regulatory circuit.              
  Pamp et al. (2006) also noted important differences in the phenotype of an spx null 
mutant of S. aureus compared to the phenotype of an spx mutant of B. subtilis as reported by 
Peter Zuber’s group.  Whereas inactivation of the spx locus in B. subtilis alleviated growth and 
development deficiencies caused by clp mutations (Nakano et al., 2001), spx mutants of S. 
aureus were obtained with very low frequency, and the colonies exhibited slow and reduced 
growth (Pamp et al., 2006).  This is due, at least in part, by the inability of the spx mutant to 
express trxB.  trxB is an essential gene in S. aureus even in the absence of oxidative stress (Uziel 
et al., 2004), and both of its promoters rely on Spx in conjunction with σA (Pamp et al., 2006).  
In contrast, trxB in B. subtilis has a σB-dependent promoter in addition to the Spx-dependent one.  
It is only essential for survival under oxidizing conditions, as B. subtilis, like S. aureus, lacks the 
glutathione/glutaredoxin system found in E. coli (Scharf et al., 1998; Uziel et al., 2004).  The 
growth defects observed in the spx mutant strain of S. aureus may also arise from the inactivity 
of various biosynthetic reductases, as thioredoxin is a hydrogen donor system for these enzymes 
(Reichard, 1993).  Since S. aureus has no alternative thiol redox system like glutathione and trxB 
expression depends on Spx, it is expected that many housekeeping functions would be hindered 
or halted in a strain lacking spx.  Indeed, it was found that purine, pyrimidine, and amino acid 
biosynthesis genes and DNA metabolism genes were both positively and negatively affected by 
deleting spx in S. aureus (Pamp et al., 2006), while these housekeeping genes were only 
upregulated in spx mutants of B. subtilis (Nakano et al., 2001).  Lastly, inactivation of spx in S. 
aureus resulted in hypersensitivity to numerous environmental stresses like sub- and 
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superoptimal temperatures, salt, and hydrogen peroxide, in addition to diamide (Pamp et al., 
2006), which is the only agent to which spx mutants of B. subtilis are known to exhibit 
hypersensitivity (Nakano et al., 2005).  Based on this evidence it appears that Spx plays a greater 
role in survival and general stress protection in S. aureus than in B. subtilis. 
In its role as a global regulator of the general stress response in S. aureus, Spx may carry 
out some of the functions that σB performs in other organisms where it has been identified.  The 
σB regulon of B. subtilis contains many of the components necessary for protection of the cell 
from damage caused by a number of environmental stresses (Hecker et al., 1996), and the 
discovery of a related alternative sigma factor in S. aureus (Kullick and Giachino, 1997) led to 
the assumption that it controlled the general stress response in this close relative of Bacillus.  But 
although the responses to heat shock, hydrogen peroxide, and acidic pH are controlled by σB in 
both organisms, responses to ethanol, salt, and osmotic shock are mediated via σB in B. subtilis 
(Boylan et al., 1993) and independently of it in S. aureus (Chan et al., 1998).  For instance, 
despite the presence of a σB recognition site in the promoter for katA, the sole catalase of S. 
aureus, catalase expression and activity was unchanged in the rsbU-positive strain, SH1000, 
compared to its otherwise isogenic parent, RN6390, even in cells experiencing oxidative stress 
(Horsburgh et al., 2002).  A global analysis of gene expression in response to diamide in B. 
subtilis found that, although over 20 % of the transcriptome was affected, expression of only a 
few σB–dependent genes was altered (Leichert et al., 2003).  The transcriptome followed a 
strikingly similar pattern of induction and repression to that of clp mutants in which Spx 
accumulates (Nakano et al., 2003a).  Spx could assume the role of σB in directing gene 
expression in response to certain types of stresses, such as disulfide stress, in both organisms.  It 
is conceivable that this regulation may involve an as-yet undiscovered alternative sigma factor.  
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A novel sigma factor, σR, was discovered in Streptomyces coelicolor that induces the thioredoxin 
system to combat oxidizing conditions (Paget et al., 1998).  Its activity is controlled by a redox-
sensing anti-sigma factor, RsrA, by a mechanism analogous to the anti-alpha activity of Spx 
(Kang et al., 1999).  Under normal conditions, RsrA binds σR, rendering it inactive.  When 
exposed to diamide or hydrogen peroxide, reversible intramolecular disulfide bond formation 
within RsrA causes dissociation of the complex and transcription of the σR regulon.  Re-
establishment of thiol homeostasis within the cell leads to reduction of RsrA and resumption of 
σR repression, completing the negative feedback regulatory loop (Kang et al., 1999).  
Repression of target gene activation by Spx has been thoroughly characterized in B. 
subtilis, and there is no evidence that it operates differently in S. aureus.  The unique mechanism 
of Spx-dependent repression is to block activator-stimulated activation of RNAP by physically 
hindering protein-protein interaction (Nakano et al., 2003b).  The two residues within the α-CTD 
of RNAP found to be essential for Spx-dependent repression are V260 and Y263, which lie 
within helix 1 of the α-CTD.  Helix 1 is important for both activator-dependent transcriptional 
activation and the binding of RNAP to UP elements of promoter DNA (Russo and Silhavy, 1992, 
Ross et al., 1993).  More evidence supporting this “interference model” exists:  Spx binds α at 
the same residues which are necessary for ComA-dependent activation of srf (Zhang et al., 2006), 
and this operon is repressed by Spx both in vivo and in vitro (Nakano et al., 2003b; Zhang et al., 
2006).  What remains unclear is whether oxidation of Spx is required for its repression activity.  
It is logical to assume that only oxidized Spx should accumulate in the cell, perhaps due to the 
diversion of the ClpXP proteolytic machinery.  The general view of Spx activity is that Spx 
accumulates at the onset of disulfide stress to repress the expression of general housekeeping 
functions in order that the cell might devote its resources to combating damage caused by the 
 64
stress, while also activating expression of thioredoxin and other genes that restore thiol balance 
(Zuber, 2004).  If this is true, then repression and activation by Spx would occur simultaneously; 
however, this is hard to test, as the redox motif of Spx has been shown to be unnecessary for 
transcriptional repression (Zhang et al., 2006), and the affinity of Spx for α is unchanged by 
oxidation state (Nakano et al., 2005).  Another gene Spx represses is hmp (Nakano et al., 2003b), 
which encodes flavohemoglobin, the expression of which is induced under oxygen-limiting 
conditions to allow anaerobic growth (Nakano et al., 2000b).  It would seem appropriate that 
expression of this gene should be inhibited when oxygen is in excess; however, evidence from S. 
aureus suggests that transient anoxic growth in response to oxidative stress can be beneficial to 
the cell by limiting additional cytotoxicity caused by ROIs produced during the normal course of 
oxidative phosphorylation (Chang et al., 2006). 
The activation activity of Spx is more mysterious, and a model to explain it does not yet 
exist.  It is not apparent how Spx could activate transcription of specific genes when it has no 
DNA-binding ability and has not been found to interact with any activator proteins productively 
(Zuber, 2004).  The crystal structure of oxidized B. subtilis Spx in complex with α-CTD was 
solved recently, and the report did suggest a possible mechanism (Newberry et al., 2005).  
Structural and genetic data indicate that Spx might activate gene expression by facilitating 
recruitment of the σ subunit to the core enzyme (Newberry et al., 2005; Zhang et al., 2006).  Spx 
was found to interact with residues on α homologous to the “261” determinant of E. coli α 
(Newberry et al., 2005), which is important for its interaction with region 4 of σ70, the 
housekeeping σ of E. coli (Savery et al., 2002).  The site of Spx’s contact with α was shown to 
be distal to the CXXC motif, which introduces the possibility that binding of oxidized Spx could 
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result in a conformational change within the α-CTD, which would then allow for α-σ interaction, 
thus permitting transcriptional activation to proceed (Newberry et al., 2005).   
It is also unknown whether disulfide bond formation between cysteines 10 and 13 is the 
only mechanism by which transcription is activated by Spx.  Newberry et al. (2006) compared 
the crystal structure of Spx-α-CTD to the published structure of E. coli ArsC, an Spx homolog, 
bound to an arsenate ion (Martin et al., 2001).  C10 of Spx aligns with the conserved arsenate-
ligating cysteine in ArsC, and these cysteines are proximal to a conserved arginine residue in 
both proteins.  The purported role of this residue in both proteins is to lower the pKa of the 
reactive cysteine, which would allow for nucleophilic attack of the thiol at physiological pH, 
favoring either ligation of the arsenate ion (Martin et al., 2001) or oxidative stress sensing 
(Newberry et al., 2005).   In both structures it was reported that a sulfate molecule which 
originated from the crystallization solution interacted with this arginine residue.  The 
significance of this finding is highlighted by the discovery that when B. subtilis is grown with 
sulfate as its sole sulfur source, Spx regulates expression of genes involved in sulfur assimilation 
and metabolism (Erwin et al., 2005).  This suggests that activation of Spx could be affected by 
other mechanisms in addition to thiol oxidation, which may be especially relevant when 
considering environmental sensing by S. aureus Spx, which controls the response to more types 
of stress than does its homolog in B. subtilis (Pamp et al., 2006). 
 Another factor complicating a model of transcriptional control by Spx in S. aureus is the 
global regulator, SarA.  This study did not attempt to discover a link between the regulatory 
pathways of Spx and SarA, but that is a future research directive of our group.  SarA does share 
some of the defining characteristics of Spx.  It affects the expression of hundreds of genes as 
both an activator and a repressor, and is responsive to redox.  Unlike Spx, SarA is a DNA-
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binding protein.  But, although consensus sequences of preferred SarA recognition sites have 
been found, SarA also can bind DNA promiscuously (Sterba et al., 2003), and may do so in vivo 
in a non-sequence specific manner.  SarA binds AT-rich DNA with high affinity (Sterba et al., 
2003).  Since UP elements which are bound by α-CTD are comprised of AT-rich sequences, 
SarA’s repression activity may be to outcompete RNAP for these activation elements, a mode of 
repression with obvious analogies to that of Spx.  SarA experiences a great increase in activity 
upon reduction of its sole cysteine residue, while Spx is activated by oxidation of its cysteine 
residues.  Since Spx induces the expression of genes involved in thiol reduction, it is possible 
that Spx enhances regulation by SarA.  Another scenario posits that only one of the two global 
regulators would be active at any specific timepoint, depending on growth phase and external 
conditions, such as pH and redox.  In this manner, SarA and Spx could coordinate virulence gene 
regulation and stress response.  This might explain why preliminary data shows antagonistic 
gene regulation by SarA and Spx in regards to biofilm production (Valle et al., 2003; Pamp et al., 
2006). 
 In order to develop an accurate model of global gene regulation by SarA and Spx, it will 
be necessary to construct S. aureus strains lacking either and both of these regulators.  Although 
in vitro experiments can be helpful in elucidating a particular mechanism of activity, the 
potential for mistaking artifacts for real data is always present, and hypotheses formulated based 
on in vitro results should be verified in vivo.  Most importantly, for the same reasons that 
pathogenesis should be studied using clinical, rather than laboratory, strains, examination of 
virulence gene expression should not be separated from the stress response.  Pathogens produce 
virulence factors within the confines of a host, which is concomitantly mounting an immune 
response and defense.  This defense can involve a number of factors, such as changes in 
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temperature, pH, redox, and cellular responses like phagocytosis and release of complement and 
cytokines, any or all of which can antagonize or aid in the offense presented by the pathogen.  In 
essence, it can be postulated that both host and pathogen present an offense and a defense, and 
each must synchronize its own gene expression to maximize the potential of both in order to 
survive.  If studies of virulence expression by prokaryotes were moved away from the ideal 
conditions of a laboratory into an environment which resembles one that these organisms 
actually encounter, perhaps more meaningful discoveries would follow.                      
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Appendix I 
 
Primers used: 
 
oJKM1:  amplify spx from RN6390 incorporating Nde I site 
 
5’ AGAGTGAGACATATGGTAACATTATTTACT 3’ 
 
oJKM2: reverse primer for oJKM1 incorporating Bam H1 site 
 
5’ TAGTAAAGTAGGATCCATAGTTAAATGGTT 3’ 
 
oJKM3: introduce C10A mutation into Spx 
 
5’ TTTACTTCACCAAGTGCTACATCTTGCCGTAAAG 3’ 
 
oJKM4: reverse primer for oJKM3 
 
5’ CTTTACGGCAAGATGTAGCACTTGGTGAAGTAAA 3’ 
 
oJKM5: introduce C13A mutation into Spx 
 
5’ CCAAGTTGCACATCTGCTCGTAAAGCGAAAGC 3’ 
 
oJKM6: reverse primer for oJKM5 
 
5’ GCTTTCGCTTTACGAGCAGATGTGCAACTTGG 3’ 
 
oJKM7:  introduce C10/13A mutation into Spx 
 
5’ CCAAGTGCTACATCTGCTCGTAAAGCGAAAGC 3’ 
 
oJKM8: reverse primer for oJKM7 
 
5’ CGTTTCGCTTTACGAGCAGATGTAGCACTTGG 3’ 
 
oJKM9: amplify rpsD fragment with promoter from RN6390 incorporating EcoR1 site 
 
5’ GCGAATTCCGGCGTCTTAGATATCGATGCC 3’ 
 
oJKM10:  reverse primer for oJKM9 incorporating Bam H1 site 
 
5’ CGGGATCCGCATGCTTACTAAGATATATTG 3’ 
 
oJKM11: amplify trxB fragment with promoter from RN6390 incorporating Eco R1 site 
 
 80
5’ CCGAATTCCCTCGAAACGTTACAAAGAAGC 3’ 
 
oJKM12: reverse primer for oJKM11 with Bam H1 site 
 
5’ GCGGATCCCATACCAGCTGGACCTGCACCG 3’ 
 
oJKM13:  amplify spx with flanking genes, trpsS and mecA, from RN6390  
 
5’ GAGGCACTAGTTAATTCT 3’ 
 
oJKM14:  reverse primer for oJKM13 
 
5’ AGACTCCAAAGAGTCTCC 3’ 
 
oJKM15:  amplify trpS from pJKM20 incorporating Sac I site 
 
5’ CTTTATTTGAGCTCTTACGTCCTAAACCCATCGC 3’ 
 
oJKM16:  reverse primer for oJKM13 incorporating Not I site 
 
5’ GATTTCATCGCGGCCCGCTTCAGTCATTTT 3’ 
 
oJKM17:  amplify mecA from pJKM20 incorporating Bam H1 site 
 
5’ CAAGAGGATCCTGGCTTATTACGTC 3’ 
 
oJKM18:  reverse primer for oJKM15 incorporating Hind III site 
 
5’ AGAGACTCCAAAGCTTCTCCTTTCATAG 3’ 
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 Appendix II 
Plasmids: 
Plasmid              Description                                                                           Source 
pCR 2.1-TOPO  E. coli subcloning vector                                                     Invitrogen 
pET9a                 Recombinant protein overexpression vector                       Novagen 
PJKM10             Wild-type Spx coding region in pCR 2.1-TOPO                This study 
pJKM11             Wild-type Spx coding region in pET9a                               This study 
pJKM12             Spx coding region bearing C10A mutation in pET9a         This study 
pJKM13             Spx coding region bearing C13A mutation in pET9a         This study  
pJKM14             Spx coding region bearing C10/13A mutation in pET9a    This study 
pLL28                E. coli-S. aureus shuttle vector to replace gene with           Chia Lee       
                           cat marker    
pJKM20             spx locus with flanking genes, trpS and mecA,                    This study  
                           in pCR 2.1-TOPO                                                   
pJKM21             trpS in pCR 2.1-TOPO                                                         This study 
pJKM22             mecA in pCR 2.1-TOPO                                                       This study 
pJKM23             trpS in pLL28                                                                       This study 
pJKM24             trpS/mecA in pLL28                                                             This study 
pJKM30             trpS/spx5’ in pCR 2.1-TOPO                                               This study 
pJKM31             mecA/spx3’ in pCR 2.1-TOPO                                             This study 
pJKM32             trpS/spx5’ in pLL28                                                             This study 
pJKM33             trpS/spx5’/mecA/spx3’ in pLL28                                         This study 
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